ARTHROPODICIDAL CARBOXANILIDES

Abstract: Arthropodicidal carboxanilides of formulae (I) and (II) wherein Q, X, X<1>, Y and G are as defined in the text, arthropodicidal compositions containing said compounds and a method for using the compounds to control arthropods.

Description: ARTHROPOD I CIDAL CARBOXANILIDES BACKGROUND OF THE INVENTION Arthropodicidal carboxanilides, compositions containing them, and use of the carboxanilides to control arthropods. Relevant to this invention are WO 88/07,994 and EPA 330,678 which disclose insecticidal pyrazolines and WO 90/07495 which discloses insecticidal semicarbazone arthropodicides. SUMMARY OF THE INVENTION The invention pertains to compounds of Formula I and II, including all geometric and stereoisomers, agriculturally suitable salts thereof, agricultural compositions containing them and their use for the control of arthropods in both agronomic and non-agronomic uses. The term "compounds" will be understood to include all such isomers and salts thereof. The compounds are: X II x- i Q—C—N- Q—C=N- II wherei : Q is selected from the group Q-l Q-2 Q-3 Q-4 Q-5 Q-6 A is H; E is selected from the group H and C1-C3 alkyl; or A and E can be taken together to form -CH2-, -CH 2 CH 2 -, -0-, -S-, -S(O)-, -S(0) 2 -, -NR 7 -, -OCH2-, -SCH2-, -N(R 7 )CH 2 -, substituted -CH2-, and substituted -CH2CH2- the substituents independently selected from 1-2 halogen and 1-2 methyl; G is selected from the group 6-1 G-2 G-3 G-4 G-5 G-6 G-7 G-8 G -9 X is selected from the group O, S and N-X 2 ; X 1 is selected from the group Cl, Br, OR 8 , SR 8 and NR 8 R 9 ; X 2 is selected from the group R 8 , OH, OR 8 , CN, SO2R , S0 Ph, OC(0)NR 9 R 10 , OC(0)OR 8 , NR 9 R 10 and phenyl optionally substituted with R 11 ; Y is selected from the group H; C ~ --Cg alkyl, benzyl; c 2~ c 6 alkoxyalkyl; C2 ~ -Cg alkenyl; C2 ~ -Cg alkynyl; C^-Cg alkyl optionally substituted by halogen, c l~ c 3 alkoxy, C1-C3 haloalkoxy, CN, θ2, S(0) r R 32 , COR 32 , C0 2 R 32 , phenyl optionally substituted by halogen, CN, C1-C2 haloalkyl and l"" c 2 haloalkoxy; C3-C5 cycloalkyl; C3-C5 cyclohaloalkyl; C3-C5 cycloalkylalkyl; CHO; C2-C6 alkylcarbonyl; C2-C5 alkoxycarbonyl; C2~-Cg haloalkylcarbonyl; COR 36 ; CO2 36 ; Cι~C alkylthio; C^-Cg haloalkylthio; phenylthio; R 12 OC(0)N(R 13 )S- and R 14 (R 15 )NS-; A 1 is H; A^ and Y can be taken together to form -(CH2) £ .-"-'■ Z is C or N; Z 1 is O, S or NR 31 ; R 1 and R 2 are independently selected from the group H, Cι~C alkyl, Cι~C haloalkyl, C2 ~ -Cg alkenyl, c 2~ c 6 haloalkenyl, C2-Cg alkynyl, Cβ-Cg haloalkynyl, C2 ~ -C alkoxyalkyl, C2~Cg alkylthioalkyl, C^-Cg nitroalkyl, C2~C cyanoalkyl, C3-C8 alkoxycarbonylalkyl, C3~Cg cycloalkyl, C3~Cg halocycloalkyl, halogen, CN, N3, SCN, N0 2 , OR 17 , SR 17 , S(0)R 17 , S(0) 2 R 17 f OC(0)R 17 , OS(0) 2 R 17 , C0 2 R 17 , C(0)R 17 , C(0)NR 17 R 18 , S0 2 NR 17 R 18 , NR 17 R 18 , NR 18 C(O)R 17 , OC(0)NHR 17 , NR 18 C(0)NHR 17 , NR 18 Sθ2R 17 , phenyl optionally substituted with 1 to 3 substituents independently selected from W, and benzyl optionally substituted with 1 to 3 substituents independently selected from W; or when m or n is 2, (R^)2 can -° & taken together, or (R 2 >2 can be taken together as -OCH2O-, -OCF2O-, -OCH2CH2O-, -CH C(CH 3 )2θ-, -CF 2 CF 0 or -OCF 2 CF 2 0- to form a cyclic bridge; provided that when R 1 or R 2 is S(0)R 17 , S(0) 2 R 17 , OC(0)R 17 or OS(0) 2 R 17 then R 17 is other than H; R 3 is selected from the group H, J, N3, NO2, halogen, N(R 22 )R 23 , C(R 34 )=N-0-R 35 , Cx-Cg alkyl, Cι.-Cg haloalkyl, C -Cg alkenyl, C2~Cg haloalkenyl, c 2~ c 6 alkynyl, C2~Cg alkoxylalkyl, C3-C8 alkoxycarbonylalkyl, CO2R 17 , OR 19 , C(0)R 17 , C(0)NR 17 R 18 , C(S)NR 17 R 18 , C(S)R 17 , C(S)SR 17 , CN, Si(R 28 ) (R 29 )R 27 , SR 27 , S(0)R 27 , S0 R 27 , -P (0) (OR 27 )2, phenyl, phenyl substituted with (R 16 )p, benzyl and benzyl substituted with 1 to 3 substituents independently selected from W; or R 3 is C2-C epoxyalkyl optionally substituted with a group selected from C1-C3 alkyl, CN, C(0)R 24 , CO2R 2 and phenyl optionally substituted with W; or R 3 is Cι~Cg alkyl substituted with a group selected from C(0)N(R 25 )R 2β , C(0)R 25 , SR 27 , S(0)R 27 , S0 2 R 27 , SCN, CN, C!-C2 haloalkoxy, Si(R 28 ) (R 29 )R 30 , N(R 22 )R 23 , N0 2 , OC(0)R 25 , -P(O) (OR 27 )2 and J; J is selected from the group saturated, partially unsaturated or aromatic 5- or 6-membered heterocyclic ring, bonded through carbon or nitrogen, containing 1-4 heteroatoms independently selected from the group consisting of 0-2 oxygen, 0-2 sulfur and 0-4 nitrogen, this substituent optionally containing one carbonyl and optionally substituted with one or more members selected from W; R 4 and R5 are independently selected from the group H, C1-C4 alkyl, COR 20 and C2-C4 alkoxycarbonyl; or R 4 and R5 can be taken together to form =0 or ~ =S; R 6 is selected from the group H, C1-C4 alkyl, C1-C4 haloalkyl, C2-C4 alkylcarbonyl, C2-C4 haloalkoxycarbonyl, C2-C4 alkoxycarbonyl C2-C4 haloalkoxycarbonyl, COR 36 , CO2R 36 , C2-C5 alkylaminocarbonyl, C 3 ~C cycloalkyl, C3~C halocycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 haloalkylcycloalkyl, C1-C4 alkylsulfonyl, C1-C haloalkylsulfonyl and S0 2 Ph optionally substituted with Cl, Br or CH3; R 7 is selected from the group H, C1-C4 alkyl, C1-C4 haloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, SR 17 , S(0)R 17 , S(0) 2 R 17 , C(0)R 17 , CO2R 17 , C(0)NR 17 R 21 , C(S)NR 17 R 21 , C(S)R 17 , C(S)OR 17 , -P(O) (OR 17 ) 2 , -P(S) (OR 17 ) 2 , P(0) (R 17 )OR 17 , P (0) (R 17 )SR 21 , and optionally substituted phenyl and benzyl wherein the substituent(s) are selected from F, Cl, Br, CH3, CF3 or OCF3; provided that when R 7 is other than C(0)R 17 , C(0)NR 17 R 21 or C(S)NR 17 R 21 then R 17 is other than H; R 8 is selected from the group C1-C3 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C3 haloalkyl, C2-C4 haloalkenyl, C3~Cg cycloalkyl; C1-C3 alkyl substituted with OCH3, OCH2CH3, NO2, CN, CO2CH3, CO2CH2CH3, SCH3 or SCH2CH3 and benzyl optionally substituted with R 11 ; R 9 is selected from the group H, C1-C4 alkyl C1-C4 haloalkyl, C2-C4 alkoxycarbonyl, and optionally substituted phenyl and pyridine wherein the substituent(s) are selected from R-- ~ ; or R 8 and R 9 can be taken together to form -(CH2)4~, -(CH2)5~ or -CH2CH2OCH2CH2- each of which is optionally and independently substituted with 1 or 2 CH3 groups; R 1 ^ is selected from the group H and C1-C4 alkyl; or R 9 and R!0 can be taken together to form -(CH2)4~, -(CH2)5" or -CH2CH2OCH2CH2- each of which is optionally and independently substituted with 1 or 2 CH3 groups; R^ 1 is selected from halogen, CN, C1-C3 haloalkyl and C1-C3 haloalkoxy; R 12 is Cι~Cg alkyl; R 13 is C1-C4 alkyl; R 14 and R 1 ^ are independently C1-C4 alkyl; or R 14 and R 15 can be taken together as -CH2CH2CH2CH2CH2- or -CH2CH2OCH2CH2-; R 16 is selected from the group C^-Cg alkyl, C^-Cg haloalkyl, C2~Cg alkenyl, C2~Cg haloalkenyl, c 2~ 6 alkynyl, C3~Cg haloalkynyl, C2~Cg alkoxyalkyl, C2~C alkylthioalkyl, C^-Cg nitroalkyl, C2~Cg cyanoalkyl, C3-C8 alkoxycarbonylalkyl, C3~Cg cycloalkyl, C3~C halocycloalkyl, halogen, CN, N 3 , SCN, O2, OR 17 , SR 17 , S(0)R 17 , S(0) 2 R 17 , OC(0)R 17 , OS(0) 2 R 17 , C0 2 R 17 , C(0)R 17 , C(0)NR 17 R 18 , Sθ2NR 17 R 18 , NR 17 R 18 f NR 18 C(0)R 17 , OC(0)NHR 17 , NR 18 C(O)NHR 17 , NR 1 Sθ2R 17 , phenyl optionally substituted with 1 to 3 substituents independently selected from W, and benzyl optionally substituted with 1 to 3 substituents independently selected from W; or when p is 2, (Rl 6 )2 can be taken together as - OCH 2 0-, -OCF 2 0-, -OCH 2 CH 2 0-, -CH 2 C(CH 3 ) 2 0-, -CF2CF2O or -OCF2CF2O- to form a cyclic bridge; provided that when R 16 is S(0)R 17 , S(0)2R 17 , OC(0)R 17 or OS(0) 2 R 17 then R 17 is other than H; R 17 is selected from the group H, Cτ.-Cg alkyl, C^-Cg haloalkyl, C2~Cg alkenyl, C2~C haloalkenyl, c 2" c 6 alkynyl, C3~C haloalkynyl, C2~C alkoxyalkyl, C 2 -Cg alkylthioalkyl, Cι~Cg nitroalkyl, C2~Cg cyanoalkyl, C3-C8 alkoxycarbonylalkyl, C3~Cg cycloalkyl, C3~Cg halocycloalkyl, and optionally substituted phenyl and benzyl wherein the substituents are 1 to 3 substituents independently selected from W; RIB is selected from the group H and C1-C4 alkyl; or R^ and R^ 8 , when attached to the same atom, can be taken together as -(^2)4-, - ( E2 ) 5~ or -CH 2 CH 2 OCH 2 CH2-; R 19 is selected from the group H, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C2-C alkylcarbonyl, C2-C4 alkoxycarbonyl and C1-C4 alkylsulfonyl; R 20 i s C!-C3 alkyl; R 2 ^ is selected from the group H, C1-C4 alkyl, C2-C alkenyl and C2-C alkynyl; R 22 is selected from the group H, C2-C7 alkylcarbonyl, C2-C7 alkoxycarbonyl, optionally substituted C1-C4 alkyl, optionally substituted c 2~ c 4 alkenyl, and optionally substituted C2-C4 alkynyl, the substituents selected from C1-C2 alkoxy, CN, C(0)R 30 and C(0) 2 R 27 ; R23 i s selected from the group H, C1-C3 alkyl, phenyl, phenyl substituted with W, benzyl and benzyl substituted with W; R 24 is selected from the group H, C1-C4 alkyl, C2-C4 alkenyl and C2-C alkynyl; R 2 ^ and R 26 are independently selected from the group H and C1-C2 alkyl; R 27 is selected from the group Cτ_—C3 alkyl, phenyl and phenyl substituted with W; R 28 is C1-C3 alkyl; R 29 is C1-C3 alkyl; R 3 0 is selected from the group H, C1-C3 alkyl, phenyl and phenyl substituted by W; R 31 is selected from the group H, C1-C alkyl, C2-C alkylcarbonyl or C2-C alkoxycarbonyl; R 32 is selected from the group C1-C3 alkyl; R 34 is selected from the group H, Cl, C1-C alkyl, C1-C4 alkoxy, C1-C2 thioalkyl and CN; R 3 5 s selected from the group H, C1-C4 alkyl, C2-C3 alkylcarbonyl and C2-C3 alkoxycarbonyl; R 36 is selected from the group phenyl and phenyl substituted with W; W is selected from the group halogen, CN, NO2, ~ ι~~ 2 alkyl, C1-C2 haloalkyl, C1-C2 alkoxy, C1-C2 haloalkoxy, C1-C2 alkylthio, C -C2 haloalkylthio, C1-C2 alkylsulfonyl and 1-C2 haloalkylsulfonyl; m is 1 to 3; n is 1 to 3; p is 1 to 3; r is 0, 1 or 2; t is 2 or 3; and u is 1 or 2. Exemplary values of J include : J-l J-2 J-3 J-4 J-5 J-6 J-7 J-8 J-9 CH 3 J-10 J-ll J-12 J-13 J-14 J-15 J-16 J-17 J-18 J-19 J-20 Preferred Compounds A are those of Formulae I and II wherein: 1 is selected from the group H, Cι~Cg alkyl, Cj-Cg haloalkyl, C2~Cg alkenyl, C2~Cg haloalkenyl, C2-Cg alkynyl, C3~Cg haloalkynyl, C 2 -Cg alkoxyalkyl, C2~Cg alkylthioalkyl, Cι.-Cg nitroalkyl, C 2 -Cg cyanoalkyl, C3-C8 alkoxycarbonylalkyl, C3~Cg cycloalkyl, C3~C halocycloalkyl, halogen, CN, SCN, O2, OR 17 , SR 17 , S0 2 R 17 , CO2R 17 , C(0)R 17 , phenyl optionally substituted with 1 to 3 substituents independently selected from W, and benzyl optionally substituted with 1 to 3 substituents independently selected from W; with one R 1 substituent in the -position, or when m is 2 then (R- 3 -)2 can be taken together as -CH 2 C(CH 3 ) 2 0-, -OCH 2 CH 2 0-, -OCF 2 CF 2 0-, or -CF2CF2O- to form a 5- or 6-membered fused ring; R 2 is selected from the group H, Cι~Cg alkyl, Cι~Cg haloalkyl, C2~Cg alkenyl, C2~Cg haloalkenyl. 2~ c 6 alkynyl, C3~Cg haloalkynyl, C2~C alkoxyalkyl, C 2 -Cg alkylthioalkyl, C^-Cg nitroalkyl, C 2 -Cg cyanoalkyl, C3-C8 alkoxycarbonylalkyl, C3~Cg cycloalkyl, C3~Cg halocycloalkyl, halogen, CN, SCN, O2, OR 17 , SR 17 , S(0) 2 R 17 , OC(0)R 17 , OS(0) 2 R 17 , C0 2 R 17 , C(0)R 17 , C(0)NR 17 R 18 , S02NR 17 R 18 , NR 17 R 18 , phenyl optionally substituted with 1 to 3 substituents independently selected from W, and benzyl optionally substituted with 1 to 3 substituents independently selected from W; R 3 is selected from the group H, C1-C4 alkyl, C3-C4 alkoxycarbonylalkyl, C0 2 R 17 , C(0)R 17 , phenyl and phenyl substituted by (R^ ) p ; R 16 is selected from the group C^-Cg alkyl, C^-Cg haloalkyl, C2~Cg alkenyl, C2~Cg haloalkenyl, C 2 -Cg alkynyl, C3~Cg haloalkynyl, C -Cg alkoxyalkyl, C -Cg alkylthioalkyl, Cι~Cg nitroalkyl, C 2 -Cg cyanoalkyl, C3-C8 alkoxycarbonylalkyl, C3~Cg cycloalkyl, C3~Cg halocycloalkyl, halogen, CN, SCN, N0 , OR^ 7 , SR 17 , S(0) 2 R 17 , OC(0)R 17 , OS(0) 2 R 17 , C0 2 R 17 , C(0)R 17 , C(0)NR 17 R 18 , S0 2 NR 17 R 18 , NR 17 R 18 , phenyl optionally substituted with 1 to 3 substituents independently selected from W, and benzyl optionally substituted with 1 to 3 substituents independently selected from W; R 17 is selected from the group C1-C alkyl, C1-C2 haloalkyl, C3-C4 alkenyl and propargyl; R^ 8 is selected from the group H and CH3; X 1 is selected from the group Cl, OR 8 , SR 8 and N(CH 3 ) 2 ; X 2 is selected from the group R 8 , OR 8 and N(CH3)2; m is 1 or 2; n is 1 or 2; and p is 1 or 2. Preferred Compounds B are those of Preferred A wherein G is selected from the group G-2, G-3, G-7 and G-9. Preferred Compounds C are those of Preferred B wherein J is selected from the group J-l, J-2, J-8, J-9 and J-l6. Preferred Compounds D are those of Preferred C wherein A and E are taken together to form -0-, -CH2-, -CH2CH2-, -OCH2-, -S-, -SCH 2 - or NR 7 ; R 7 is selected from the group H, Me, S0 2 R 17 , C0 2 R 17 and C0N(R 17 )R 21 . Preferred Compounds E are Compounds D of Formula I wherein Z-~ is 0. Preferred Compounds F are Compounds D of Formula I wherein Z 1 is S. Preferred Compounds G are Compounds D of Formula I wherein Z~- is NR 3:L . Preferred Compounds H are those of Preferred E wherein Q is Q-l. Preferred Compounds I are those of Preferred E wherein Q is Q-2. Preferred Compounds J are those of Preferred E wherein Y is C^-Cg alkyl. Preferred Compounds K are those of Preferred J wherein Y is CH3. Specifically preferred are compounds: (L) methyl 7-chloro-2,3-dihydro-2-[[4-trifluoro- ethox )phenylamino]carbonyl]indeno[1,2-e]- [1,3,4]oxadiazine-4a(5H)-carboxylate; (M) methyl 7-chloro-2,5-dihydro-2-[N-methyl-N-[4- (trifluoromethoxy) henyl]aminocarbonyl]indeno- [1,2-e] [1,3,4]oxadiazine-4a(3H)-carboxylate; (N) methyl 7-chloro-2,5-dihydro-2-[[N-methyl-N-[4- trifluoromethyl)phenyl]amino]carbonyl]indeno- [1,2-e] [l,3,4]oxadiazine-4a(3H)-carboxylate; (0) 7-fluoro-4a-(4-fluorophenyl)-4a,5-dihydro-N-[4- (trifluoromethoxy)phenyl]indeno[l,2-e] [1,3,4]- oxadiazine-2 (3H)-carboxamide; and (P) 7-chloro-4a,5-dihydro-4a-methyl-N-[4-(trifluoro- methoxy)phenyl]indeno[1,2-e] [1,3,4]oxadiazine- 2 (3H)-carboxamide. In the above definitions, the term "alkyl", used either alone or in compounds words such as "alkylthio" or "haloalkyl", denotes straight chain or branched alkyl, such as methyl, ethyl, n-propyl, isopropyl or the different butyl, pentyl, hexyl isomers. Alkoxy denotes methoxy, ethoxy, n-propyloxy, isopropyloxy and the different butoxy or pentoxy isomers. Alkenyl denotes straight chain or branched alkenes, such as vinyl, 1-propenyl, 2-propenyl, 3-propenyl and the different butenyl, pentenyl and hexenyl isomers. Alkynyl denotes straight chain or branched alkynes, such as ethynyl, 1-propynyl, 3-propynyl and the different butynyl, pentynyl and hexynyl isomers. Alkylthio denotes methylthio, ethylthio and the different propylthio, butylthio, pentylthio and hexylthio isomers. Alkylsulfinyl, alkylsulfonyl, alkylamino, and the like are defined analogously to the above examples. Cycloalkyl denotes cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. The term "halogen", either alone or in compound words such as "haloalkyl", denotes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as "haloalkyl" said alkyl may be partially or fully substituted with halogen atoms, which may be the same or different. Examples of haloalkyl include CH 2 CH 2 F, CF2CF2 and CH 2 CHFC1. The terms "halocycloalkyl", "haloalkenyl" and "haloalkynyl" are defined analogously to the term "haloalkyl". The total number of carbon atoms in a substituent group is indicated by the "C -Cj" prefix where i and j are numbers from 1 to 8. For example, C1-C3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl; C 2 alkoxyalkoxy designates OCH2OCH3; C4 alkoxyalkoxy designates the various isomers of an alkoxy group substituted with a second alkoxy group containing a total of 4 carbon atoms, examples including OCH2OCH2CH2CH3 and OCH2CH2OCH2CH3; C 2 cyanoalkyl designates CH2CN and C3 cyanoalkyl designates CH2CH2CN and CH(CN)CH3; C2 alkylcarbonyl designates C(0)CH3 and C4 alkylcarbonyl includes C(0)CH 2 CH CH3 and C(0)CH(CH 3 ) 2 ; C 2 alkoxycarbonyl designates C(0)OCH3 and C4 alkoxycarbonyl designates C(0)OCH2CH2CH3 and C(0)0CH(CH3)2; and as a final example, C3 alkoxycarbonylalkyl designates CH2CO2CH3 and C4 alkoxycarbonylalkyl includes CH2CH2CO2CH3, CH2CO2CH2CH3 and CH(CH3)C0 2 CH 3 . DETAILS OF THE INVENTION Compounds of Formulae I and II are prepared as described in Schemes 1 through 30 with substituents as previously defined, unless otherwise noted. The substituents R 4 and R^ have been depicted as hydrogen for the purposes of clarity but also included are the values of these substituents as previously defined. Compounds of Formula II (Q-l) can be prepared by the reaction of imidoylhalides of Formula II (Q-l) with sulfur, oxygen and nitrogen nucleophiles of Formula III as illustrated in Scheme 1. Typical reactions involve the combination of equimolar amounts of II (Q-l) and III in the presence of a base such as an alkali metal, tertiary amine, metal hydride and the like in conventional organic solvents, including ether, tetrahydrofuran, 1,2-dimethoxyethane, methylene chloride. chloroform, N,N-dimethylformamide and dimethylsulfoxide. The reaction can be conducted at temperatures ranging from -20°C to 100°C with temperatures in the range of -10°C to 30°C generally being preferred. One skilled in the art will recognize that reactions of this general type can be extended to other nucleophilic reagents. SCHEME 1 II (Q-i) X--=Cl,Br The imidoylhalides of Formula II (Q-l) can be prepared by the reaction of Formula I (Q-l) compounds with an appropriate halogenating agent such as phosphorous trichloride, phosphorous pentachloride, phosphorous tribromide, phosphorous pentabromide, thionyl chloride, sulfuryl chloride, triphenyl phosphine and carbon tetrachloride (Wolkoff, Can. J. Chem., 1975, 53, 1333) and the like (see Fieser and Fieser, Reagents for Organic Synthesis, Vol. I, 1967) as illustrated in Scheme 2. Typical reactions involve the combination of Formula I (Q-l) compounds with an excess of the halogenating agent ranging from 1.1 to 10 equivalents, with 2 to 4 equivalents being preferred. The reaction can be conducted in the absence of a solvent or in the presence of a conventional organic solvent such as benzene, toluene, xylene, chloroform, methylene chloride, hexane and the like. The reaction temperature can range from -10°C to 200°C with 35°C to 100°C being preferred. The reaction is generally complete after 24 hours. SCHEME 2 I (Q-l) x=o Alternatively, compounds of Formula II (Q-l) , when X 1 is equal to R 8 -S, can be prepared by the reaction of compounds of the Formula I (Q-l) where X is equal to S with an electrophile of the Formula IV in the presence of a suitable base, as illustrated in Scheme 3. Typical reactions involve the combination of equimolar amounts of Formula I (Q-l) compounds and the appropriate electrophile of Formula IV. A base such as an alkali metal, tertiary amine or metal hydride can be used. SCHEME 3 I (Q-l) X=S Compounds of Formula I (Q-l) where X is S or 0 can be prepared by the reaction of Formula V compounds with isocyanates of Formula VI. Typical reactions involve the combination of equimolar amounts of V and VI in a conventional organic solvent such as but not limited to ethyl acetate, methylene chloride, chloroform, benzene or toluene. A base such as an alkali metal, tertiary amine, alkali metal alkoxide or metal hydride can be used. Scheme 4 illustrates this transformation. SCHEME 4 V VI X =0, S Alternatively, compounds of Formula I (Q-l) , where A and E are taken together to form a 1- or 2-atom bridge, as previously described, can be prepared by the reaction of semicarbazones of Formula VII with compounds of Formula VIII. Typical reactions involve the combination of an excess in molar amounts of a Formula VIII compound (1.1 equivalents to 40 equivalents) with 1 equivalent of a Formula VII compound in the presence of less than one molar equivalent of an acid catalyst (0 equivalents to 0.9 equivalents). Typical acid catalysts include alkyl or aryl sulfonic acids (such as methyl, camphor or p-toluene sulfonic) and mineral acids (such as hydrochloric or sulf ric) . Conventional, polar organic solvents such as acetonitrile, dimethylformamide, tetrahydrofuran, methanol or ethanol can be used. The reaction temperature can vary from 0°C to the reflux temperature of the particular solvent being used and the reaction is usually complete in less than 24 hours. Scheme 5 illustrates this transformatio . SCHEME 5 VII is O or S wherei : R 4 and R^ are not taken together to form =0 or -S . Alternatively, compounds of Formula I (Q-l), where A and E are taken together to form a 1- or 2-atom bridge, as previously described, can be prepared by the reaction of compounds of Formula VII with compounds of Formula IX (see Scheme 6) . Typical reactions involve combination of an excess in molar amounts of a Formula IX compound (1.1 equivalents to 5.0 equivalents) with one equivalent of a Formula VII compound in the presence of a base such as a tertiary amine (such as triethylamine, pyridine or DBU) , an alkali metal, an alkali metal hydride or an alkali metal alkoxide or hydroxide (such as sodium methoxide, potassium-t- butoxide, sodium hydroxide or potassium hydroxide) . Conventional, polar organic solvents such as methanol, ethanol, propanol, dimethylformamide, THF, dichloromethane or acetonitrile can be used. The reaction temperatures can vary from 0°C to the reflux temperature of the particular solvent being used and the reaction is usually complete in less than 24 hours. Alternatively, when Z 1 - NR 31 , R 4 and R 5 - H and L 1 and L 2 are taken together as the reaction can be performed in the absence of base in aprotic solvents such as THF, dioxane and the like. Equimolar amounts of VII and IX are used and the reaction is usually complete in 72 hours. SCHEME 6 VII + R 4 R 5 CL--L 2 m- I (Q-l) base IX wherein: , L 2 are Cl, Br, I, imidazole, or L! and L 2 may be taken together to equal =0, =S or ~~~ N(CH3)2 Φ I Θ (where zl is NR 3i ) provided that R 4 and R 5 are not taken together to form «-=0. Compounds of Formula V, where A and E are taken together to form a 1- or 2-atom bridge, as previously described, can be prepared by the reaction of Formula X compounds with either compounds of Formula VIII or compounds of Formula IX using methods analogous to those shown for the preparation of Formula I (Q-l) compounds in Schemes 5 and 6. The preparation of Formula V compounds is shown in Scheme 7. SCHEME 7 X is 0 or S Compounds of Formula VII where X is 0 or S can be prepared by the reaction of Formula X compounds with isocyanates of Formula VI as shown in Scheme 8. Typical reactions involve the combination of equimolar amounts of X and VI in the presence of 1 molar equivalent of water in a polar organic solvent such as tetrahydrofuran or dimethylformamide. The reaction is usually complete in less than 24 hours SCHEME 8 X + VI ~~~ VII x ~ =o, S Alternatively, Formula VII compounds where X is 0 or S can be prepared by the reaction of compounds of Formula XI with semicarbazides of Formula XII. Conditions for this reaction optionally include an acid catalyst such as hydrochloric, sulfuric or p-toluene sulfonic acid. Reaction temperatures can range from 0 to 150°C with the reflux temperature of the solvent used generally preferred. Suitable solvents include, but are not limited to, methanol, ethanol, isopropanol, tetrahydrofuran and dioxane. Scheme 9 illustrates this transformation. SCHEME 9 XI XII X 3 is O S, NR 31 , x-o, s NHR Cl The preparation of Formula X compounds can be accomplished by the reaction of Formula XI compounds with an excess of equivalents (1.1 to 10.0 equivalents) of hydrazine, hydrazine monohydrate, hydrazine acetate, hydrazine hydrochloride and the like. The reaction is conducted in an alcohol solvent such as methanol, ethanol, n-propanol, isopropanol, n-butanol and the like or acetic acid and the temperature is governed by the reflux temperature of the particular solvent. The reaction is generally complete in 24 hours. Scheme 10 illustrates this transformation. SCHEME 10 NH 2 NH 2 , XI X NH 2 NH 2 ,H 2 0 or NH 2 NH 2 # HOAc Compounds of Formula XI where X 3 is O can be prepared by the α-hydroxylation of ketones of Formula XIII using procedures that are well-known to one skilled in the art (e.g., J. Am. Chem. Soc, 1974, _a£, 5944; Tetrahedron Lett., 1988, 2.1, 2835; J. Org. Chem., 1986, 5L, 2402) . Scheme 11 illustrates this transformation. SCHEME 11 Numerous alternative procedures exist for the preparation of α-hydroxyketones of Formula XI (where X 3 is 0) . Such procedures are well-known to one skilled in the art (March, Advanced Organic Chemistry, 3rd Edition, 1985, p. 1164) . Compounds of Formula XI where X 3 is O, R 3 is aryl and E is H are benzoins whose preparations are well-known to one skilled in the art. α-Keto sulfides of Formula XI where X 3 is S can be prepared from ketones of Formula XIII using procedures known to the art (J. Am. Chem. Soc, 1985, 107, 4175; J. Org. Chem., 1988, 5_3., 3125). α-Amino ketones of Formula XI where X 3 is R 3 ^- can be prepared from ketones of Formula XIII using procedures known in the art (J. Chem. Soc, 1959, 1479; Synthesis, 1972, 191) . Compounds XI where X 3 is NHR 3 1®C1 Θ , can be prepared by the reaction of Formula XIII compounds with compounds of the type Xllla using a procedure similar to those described in the art (Synthesis, 1991, 327) . The conditions for this reaction are the combination of equimolar amounts of Formulae XIII and Xllla derivatives in the presence of a base as a catalyst, such as, but not limited to, DABCO, DBU, sodium hydroxide and the like. Suitable solvents include, but are not limited to, toluene, dioxane and water. Scheme 11a illustrates this transformation. SCHEME 11a XIII Xllla XI Φ θ X 3 -NHR 31 C1 The starting ketones of Formula XIII are known in the art or can be obtained by methods analogous to known procedures. Those skilled in the art will recognize the Formula XIII compounds to include indanones, tetralones, chromanones, thiochromanones, benzofuran-3-ones, isochromanones and others. One skilled in the art will recognize that the transformation of Formula XIII compounds into Formula XI compounds may require the use of protecting groups to prevent unwanted side reactions of functionalities that may be sensitive to the reaction conditions (for example, an indoxyl nitrogen atom may require a protecting group to render it unreactive in an α-hydroxylation of the carbonyl group) . Since numerous alternative synthetic methods for the preparations of Formula XI compounds exist, a further discussion of protecting-group chemistry will be omitted. Semicarbazides of Formula XII where X is O or S and G is G-9 can be prepared using procedures well-known to those skilled in the art. Formula XII compounds where X is O or S and G is G-l to G-8 can be prepared by using the procedure shown in Scheme 12. SCHEME 12 X GNH 2 + L 1 L 2 C=X «-- GNHCL 2 XIV XV XVI NH 2 NH 2 XVI ^ XII or NH 2 NH 2 »H 2 0 wherein: G is G-l through G-8 and L 1 and L 2 are as already defined. Typical reaction conditions involve the reaction of equimolar amounts of an amine of Formula XIV with a compound of Formula XV (usually, 1,1'-carbonyl- diimidazole or thiophosgene are preferred) in a suitable solvent at a temperature between -20°C and 50°C. Suitable solvents include, but are not limited to, methylene chloride, chloroform, tetrahydrofuran or dioxane. The reaction product, XVI, is used without purification and is treated with an excess of a molar amount of hydrazine or hydrazine hydrate in an alcohol solvent such as methanol, ethanol or isopropanol at a temperature from 0 to 110°C with the preferred temperature being the boiling point of the solvent used. The formation of semicarbazide XII is usually complete within 72 hours. Compounds of Formula I, where Q is Q-l and G is equal to G-l through G-8 can be prepared by treating intermediates of Formula V with triphosgene (0-=C(0CCl3) 2 ) or phosgene and NH 2 -G in the presence of a base such as pyridine as outlined in Scheme 13. SCHEME 13 cι 2 co V I Compounds of Formula II (Q-2) can be prepared from Formula II (Q-2) imidoylhalide derivatives in an analogous fashion such as that described for the preparation of Formula II (Q-l) imidoylhalide compounds; see Scheme 14. SCHEME 14 II (Q- 2 ) X 1 =Cl,Br Formula II (Q-2) imidoylhalide compounds can be prepared from Formula I (Q-2) compounds in an analogous fashion as that described for Formula II (Q-l) compounds; see Scheme 15. SCHEME 15 I (Q-2) Compounds of Formula I (Q-2) can be prepared by the reaction of the acid chloride XVI with a substituted aniline of Formula XVII in equimolar proportions in the presence of an excess of an acid scavenger, such as tertiary alkylamines or pyridines, but not limited to these, in an aprotic organic solvent such as ether, tetrahydrofuran, chloroform, methylene chloride, benzene and/or toluene. Scheme 16 illustrates this transformation. SCHEME 16 XVI XVII Compounds of the Formula XVI can be prepared from compounds of the Formula XVIII through conventional methodology generally used for the conversion of esters to their corresponding acid chlorides as illustrated in Scheme 17. SCHEME 17 XVIII Formula XVIII derivatives (where A is equal to H) can be prepared by the reaction of Formula XIX compounds with an equimolar or greater amount of a Formula XX compound in the presence of an acid catalyst (with 0.05 to 0.2 molar equivalents preferred) . The reaction can be carried out in a variety of polar organic solvents, including, but not limited to, tetrahydrofuran, acetonitrile, methanol or ethanol at a temperature of between 0 and 80°C with the preferred temperature being the reflux temperature of the solvent. This reaction is illustrated by Scheme 18. SCHEME 18 XVIII (A is H) COΛCH CHQ XIX (A is H) Compounds of Formula XIX where Z 1 is O can be prepared by treatment of Formula XXI compounds with a carboxylic acid such as formic, acetic or benzoic acid in the presence of 0 to 2.0 equivalents of a base including, but not limited to, potassium carbonate, sodium carbonate or sodium hydroxyde. Suitable solvents for the reaction include, but are not limited to, ethanol, tetrahydrofuran or dimethylformamide. The ester XXII formed in the initial reaction is subsequently hydrolyzed to the alcohol XIX (z is O) using a base such as sodium ethoxide in a solvent such as ethanol. Thiols of the Formula XIX (where zl is S) can be prepared using analogous procedures starting with a thiocarboxylic acid (such as thiolacetic acid) . The preparations of Formula XIX compounds (z is 0 or S) are illustrated by Scheme 19. SCHEME 19 CO CH CH CO CH CH-a XXI XXII NaOEt XXII XIX (Z- is O or S) wherein: is O or S; R 32 is H, alkyl or aryl. Compounds of Formula XIX where z is NR 3 can be prepared using procedures analogous to those shown in Scheme 19 using either ammonia or a primary amine ( R 31JJH 2 ) in place of the carboxylic or thiocarboxylic acid. Compounds of Formula XXI can be prepared from compounds of the Formula XXIII by the reaction with an equimolar amount of XXIV in conventional organic solvents such as, but not limited to, ether, tetrahydrofuran, methanol, ethanol, methylene chloride, benzene and toluene. Typical reaction temperatures can range from room temperature to the reflux temperature of the particular solvent utilized and the reaction is usually complete in 24 hours. Scheme 20 illustrates this reaction. SCHEME 20 XXIII XXIV Formula XXIII compounds can be prepared from Formula XXV derivatives by a diazotization/reduction reaction well documented in the literature (see Organic Functional Group Preparation, 1983, pp. 452-453 and references cited therein) . Scheme 21 illustrates this transformation. SCHEME 21 XXIII XXV Formula XXV compounds are known in the art or can be obtained by methods analogous to known procedures. Those skilled in the art will recognize Formula XXV compounds to be substituted anilines or aminopyridines. Compounds of Formula I (Q-3) can be prepared by the reaction of tri- and tetravalent metal species such as titanium, silicon, tin and the like in combination with reducing agents such as sodium, lithium, or zinc borohydride, lithium aluminum hydride and the like with compounds of Formula I (Q-l) as illustrated in Scheme 22. Literature precedent for analogous reactions can be found in .Orςr. Chem.. 1987, 54, 3750, and Synthesis, 1980, 695. Typical reactions involve the addition of 1 equivalent of a compound of Formula I (Q-l) to a solution of 1.1 to 4.0 equivalents of titanium tetrachloride, with 1.5 to 2.5 equivalents being preferred, and 2.1 to 6.0 equivalents of sodium borohydride with 3.5 to 4.5 equivalents being preferred. Conventional organic solvents such as ether, tetrahydrofuran, dimethoxyethane, methylene chloride and chloroform can be used with 1,2-dimethox ethane being preferred. The reaction can be conducted at temperatures ranging from -70°C to 50°C with -10°C to 30°C being preferred. The reaction time can be 0.1 hour to 48 hours with 2 to 4 hours being preferred. SCHEME 22 I (Q-l) Formula I (Q-3) derivatives can be converted into Formula II (Q-3) compounds in an analogous fashion as described for the conversion of Formula I (Q-l) compounds into Formula II (Q-l) derivatives. Formulae I (Q-4) and II (Q-4) compounds can be prepared in an analogous fashion as described for the preparation of Formulae I (Q-3) and II (Q-3) derivatives. Additionally, compounds of Formula I, where Q is Q- 1, A is H, Z is CH, E is H and R 3 is H, alkyl or aryl, can be prepared as outlined in Scheme 23. This is generally accomplished by the reaction of equimolar amounts of a heterocycle such as XXVI with an aryl isocyanate or isothiocyanate of Formula VI in conventional organic solvents such as ether or tetrahydrofuran. The Formula I compounds of Scheme 23, where E is H, can be converted to the analogs where E is C1-C3 alkyl by alkylation of the dianion with a C1-C3 alkyl halide as shown. This is typically done by treatment of the compound where E is H with at least two equivalents of a strong base such as lithium diisopropy1amide at low temperatures in the range of O to -78°C in a solvent such as tetrahydrofuran. An alkyl halide (typically the iodide) is then added to the preformed dianion affording, after workup, compounds of Formula I where Q is Q-l, A is H and E is C1-C3 alkyl. SCHEME 23 (E is C^-03 alkyl) Alkylation of the dianion of compounds such as XXVII is another useful method for the introduction of a variety of R 3 groups, this method is outlined in Scheme 24. The R 3 groups generally prepared by this method are derived from alkylating reagents R 3 -L (where L is Cl, Br or I) and include, e.g., alkyl halides, substituted alkyl halides, acyl halides, alkylchloroformates, sulfenyl and sulfonyl halides, dialkylcarbamoyl halides and the like. Typical procedures are analogous to that described in Scheme 23 and include the use of strong base at low temperature. A second substituent E (where E is C1-C3 alkyl) can also be introduced in a similar fashion. SCHEME 24 I XXVII (R 3 is, e.g., C0 2 R 17 , COR 17 , C0NR 17 R 18 , SR 27 , S0 2 R 27 ) Compounds of Formula I, where Q is Q-l and R 4 and R5 are taken together to form a carbonyl group (such as compound XXVIII) can be prepared by the reaction of an amide such as V, where R 4 and R^ are taken together to form =0, with an aryl isocyanate or isothiocyanate. This method is outlined in Scheme 25. This reaction can be run in a variety of conventional organic solvents such as ether, tetrahydrofuran or ethyl acetate and is preferably conducted at the reflux temperature of the solvent. It is also preferable, and in some cases necessary, to add a catalytic amount of an amine base such as triethylamine, pyridine or preferably N,N-dimethylaminopyridine. SCHEME 25 (R 4 and R 5 are taken XXVIII together to form «0) Compounds of Formulae I (Q-5) and II (Q-5) can be prepared by the reaction of Formulae I (Q-l) and II (Q-l) derivatives where z is NH and R 4 is H with an oxidizing agent, such as dichlorodicyanobenzoquinone (DDQ) (see Fieser and Fieser, Reagents for Organic Synthesis, 1967, Vol. I, pp. 215-219). The reaction involves the combination of an excess of molar equivalents of DDQ with one molar equivalent of Formula I (Q-l) or Formula II (Q-l) compounds where zl is NH and R 4 is H in a suitable solvent such as, but not limited to, methanol, ethanol, acetone and benzene. The reaction is conducted at room temperature to reflux temperature of the particular solvent utilized. The reaction is usually complete in 24 hours. Scheme 25a illustrates this reaction. SCHEME 25a I (Q-l) I (Q-5) Compounds of Formulae I (Q-6) and II (Q-6) can be prepared in an analogous fashion as described in Scheme 25a for Formulae I (Q-5) and II (Q-5) derivatives. Formulae I compounds where Y is other than H, can be prepared by standard alkylation, acylation or sulfenylation methods well documented in the literature. Formula I compounds where Y and A! are taken together to form -(CH2) ~ can be prepared by coupling of a Formula V compound with an indoline (t is 2) or tetrahydroquinoline (t is 3) of Formula XXIX in the presence of phosgene or a phosgene equivalent. Typical reaction conditions involve combination of di- or triphosgene with the Formula V compound in a solvent such as tetrahydrofuran or chloroform followed by addition of the indoline or tetrahydroquinoline of Formula XXIX. This chemistry is depicted in Scheme 26. SCHEME 26 XXIX t is 2 or 3 The indoline (t is 2) and tetrahydroquinoline (t is 3) of Formula XXIX are well known in the art as well as procedures for their preparation. Alternatively, compounds of Formula I where Y and A! are taken together to form -(CH2) ~ can be prepared by the reactions semicarbazones of Formula XXX with compounds of Formula VIII, as depicted in Scheme 27. Procedures for this transformation are analogous to those described for Scheme 5. SCHEME 27 (CH 2 ) 1 XXX Compounds of Formula XXX can be prepared by the reaction of Formula XI compounds with semicarbazides of Formula XXXI using procedures analogous to those described for Scheme 9. The formation of Formula XXX compounds is depicted in Scheme 28. SCHEME 8 X XXXI The formation of Formula XXXI semicarbazides can be achieved using procedures analogous to those described in Scheme 12 for Formula XII compounds. Alternatively, compounds of Formula I can be prepared by the reaction of Formula XXXII compounds with anilines of Formula XVII as depicted in Scheme 29. SCHEME 29 XXXII wherein: L 3 is an alkoxy or aryloxy leaving group and z is 0 or S. Typical reaction conditions involve the reaction of XXXII with between 1 to 5 molar equivalents of XVII in a suitable solvent in the presence of 0 to 10 molar equivalents of a base such as pyridine, potassium carbonate or triethylamine. Suitable solvents include THF, DMF and acetonitrile. Formula XXXII compounds can be prepared by the reaction of a Formula XXXIII compound with an alkyl or aryl chloroformate of Formula XXXIV, as depicted in Scheme 30. The reaction is generally carried out using an excess of one molar equivalent of XXXIV in a non- nucleophilic solvent such as benzene or xylenes. Alternatively, the reaction can be carried out in the absence of solvent. Reactions are generally run at temperatures between 20-100°C. SCHEME 3Q A Cl XXXII XXXIV XXXIII wherei : L 3 is an alkoxy or aryloxy group and Z 1 is O or S. Formula XXXIII compounds are oxadiazines and thiadiazines whose preparations are known to the literature (see, e.g., Synthesis, 1988, 208; Synthesis, 1990, 491). The following Examples further illustrate the invention. Example 1 Step A: 3-Chloro-r-t- -πhlorophenyl)benzenepropanoic acid To a solution of 6.8 g (0.17 mol) of 60% sodium hydride in 150 ml of dimethylformamide under nitrogen was added 30.0 g (0.162 mol) of methyl 4-chloro- phenylacetate dropwise such that hydrogen evolution was moderate and the temperature of the reaction was maintained at less than 50°C. Once hydrogen evolution had ceased, a solution of 33.2 g (0.162 m) of 3-chlorobenzylbromide in 30 ml of dimethylformamide was added very cautiously such that the reaction temperature was maintained at less than 60°C. The reaction was maintained at 50 to 60°C with stirring overnight after which time it was partitioned between 5% aqueous aHCθ3 and diethyl ether, the aqueous extracts were washed twice with ether and the combined organic extracts were then washed with water. The ether extracts were dried over gS0 , filtered and concentrated to afford 48.0 g of a brown oil. The crude product was combined with 300 ml of methanol, 40 ml of water and 20 ml of 50% aqueous sodium bydroxide and refluxed overnight. After this time the reaction was concentrated and the crude residue partitioned between water and ether. The aqueous extracts were acidified with cone, hydrochloric acid and extracted several times with ether. The ether extracts were dried over MgS04, filtered and concentrated to 48.8 g of a yellow, oily solid. -Ε NMR (CDC1 3 ) δ 3.0 (dd, 1H) , 3.3 (m, 1H) , 3.84 (t, 1H) , 6.11 (d, 1H), 6.9-7.4 ( ) . Step B: 5-Chloro-2-(4-chlorophenylϊ-2.3-dihydro-lH- inden-1-one The crude product from Step A was combined with 50 ml of thionyl chloride and then heated at reflux for 2 hours. Thionyl chloride was removed by concentration at reduced pressure and then the mixture was concentrated several times from carbon tetrachloride. The residue was combined with 200 ml of dichloroethane, cooled under nitrogen to 0°C, and 24.5 g of aluminum trichloride was then added. After stirring overnight the reaction was poured onto a mixture of ice in IN hydrochloric acid, extracted three times with ether and chromatographed on silica gel (10% ethyl acetate/hexane) to afford 18.6 g of a yellow oily solid. 1H NMR (CDCI3) δ 3.20 (dd, 1H) , 3.68 (dd, 1H) , 3.90 (dd, 1H), 6.9-7.6 (m, 6H) , 7.75 (d, 1H) . Step C: S-Chloro-2-(4-chlorophenyl>-2.3-dihydro-2- hydroxy-lH-inden-1-one A solution of 2.4 g (0.009 moles) of the product obtained from Step B and 20 L of toluene was added with stirring to a mixture of 1.8 g (0.010 moles) of triethylphosphite, 0.1 g (0.0004 moles) of benzyl- triethyl ammonium chloride, 100 mL of toluene and 50 mL of 50% aqueous sodium hydroxide solution. A steady stream of air was introduced into the vigorously stirred reaction mixture at room temperature for 1 hour. The resulting mixture was partitioned between 100 mL of Et2θ and 200 mL of water and the aqueous layer was extracted with two 100 mL portions of Et2θ. The combined organic layers were washed twice with 100 mL of water, twice with saturated aqueous sodium bisulfite solution, dried over MgSθ4 and concentrated. The resulting crude product was chromatographed on silica gel using 2:1 hexanes-ethyl acetate to give 1.2 g of an oil that solidified on standing. --E NMR (CDCI3) δ 3.23 (broadened s, 1H) , 3.54 (apparent s, 2H) , 7.25 (abq, 4H) , 7.44 (d, 1H) , 7.53 (broadened s, 1H) , 7.78 (d, 1H) . Step D: 2-r5-Chloro-2-(4-chlorophenylϊ-2 r 3-dihydro-2- hydroxy-lH-inden-1-ylidenel-N-T4-(trifluoro- methyl )phenyl1hydrazine-carboxamide A solution of 1.0 g (0.003 moles) of the product obtained in Step C, 0.66 mL (0.014 moles) of hydrazine monohydrate and 17 mL of ethanol was heated at reflux for 3 hours. The resulting solution was partitioned between water and CH2CI2 and the aqueous layer was extracted with CH 2 C1 2 . The combined organic layers were washed twice with water, dried over MgSθ4 and concentrated. The residue was chromatographed on silica gel using 1:1 hexanes-ethyl acetate to give 0.53 g of a yellow solid. A solution of 0.5 g of the above product, 0.24 mL (0.0016 moles) of α,α,CC-trifluoro-p-tolyl isocyanate, 25 mL of tetrahydrofuran and 1 mL of water was stirred at room temperature for one hour and then concentrated. The residue was suspended in acetonitrile and concentrated to give 0.60 g of a white solid, melting point, 225°C (decomposes) . X H NMR (d6~DMSO) 83.3 (d, 1H, partially obscured by H 2 0 peak), 3.55 (d, 1H) , 7.3-7.5 (m, 7H) , 7.64 (d, 2H) , 7.82 (d, 2H), 8.00 (d, 1H), 9.52 (broadened s, 1H) . Step E: 7-Chlo--ro- a- -chlorophan l)-4a r 5-riihydro-N-T4- f rifluoromethy3 hP-nyl1-indenori r 2-e1- ri. . 1oxadiazine-213")-carboxamide A mixture of 0.30 g (0.0006 moles) of the product obtained in Step D, 0.36 g (0.012 moles) of paraformaldehyde, 50 mg of p-toluene sulfonic acid monohydrate and 30 mL of acetonitrile was refluxed for 1 hour. The resulting mixture was partitioned between CH2CI2 and saturated aqueous sodium bicarbonate and the aqueous layer was extracted twice with CH 2 C1 2 - The combined organic layers were dried over MgS04 and concentrated to give an oil that was chromatographed on silica gel using 4:1 hexanes-ethyl acetate to give 0.23 g of an oil that solidified on standing, melting point, 213-214°C. 1H NMR (CDCI3) δ 3.39 (d, 1H) , 3.58 (d, 1H) , 4.54 (d, 1H), 5.78 (d, 1H), 7.20-7.42 ( , 6H) , 7.61 (abq, 4H) , 7.72 (d, 1H) , 8.58 (broadened s, 1H) . Example 2 Step A: Methyl 5-chloro-2.3-dihydro-2-hydroxy-l-oxo-lH- indene-2-carboxylate Sodium hydride (24 g of 60% solution in oil, 0.6 moles) was washed with hexanes to remove the oil. The resulting washed NaH was suspended in 200 mL of DMF and then treated with a solution of 50 g (0.3 moles) of 5-chloro-l-indanone and 150 mL of DMF at such a rate that reaction temperature remained below 35°C. The resulting mixture was stirred for 30 min and then treated with 38 L (0.45 moles) of dimethyl carbonate added over 15 min. The resulting mixture was stirred at room temperature for 1.5 h and then allowed to stand overnight. The reaction mixture was poured carefully into a mixture of 100 mL of concentrated HC1 and about 1000 mL of ice. Then, 500 L of ether was added and the aqueous layer was extracted twice with ether. The combined organic layers were washed with three portions of H2O, dried (MgSθ ) and concentrated to give 64.6 g of a brown oil. A solution of 5.0 g (0.022 moles) of the above product and 70 L of methylene chloride was treated with 10 g (ca. 0.032 moles) of 50-60% -chloroperbenzoic acid (Aldrich) at room temperature. After 1 h, the reaction was cooled to 0°C and quenched by careful addition of saturated aqueous sodium carbonate. The layer was washed twice with saturated aqeuous sodium carbonate, once with saturated sodium bisulfite, dried (MgSθ ) and concentrated to give 4.0 g of a yellow solid. IR (CCI4 solution) 3560, 1770, 1745 cm" 1 . !H NMR (CDCI3, 200 mHz) δ 7.73 (d, IH) , 7.50 (br s, IH) , 7.42 (d, IH) , 4.04 (s t IH, exchangeable with D2O) , 3.75 (s, 3H) , 3.69 (d, IH) , 3.24 (d, IH) . step B: Methyl 5-c loro-2,3-dihydro-2-hydroxy-r \ \T4- (trifluoromethoxy)phenyl1aminolcarhonyllhydro- zono]-lH-indene-2-carboxylate A solution of 1 g (0.004 moles) of the product from Step A and 10 mL of methanol was added to a solution of 0.61 mL (0.012 moles) of hydrazine monohydrate, 0.72 mL (0.012 moles) of glacial acetic acid and 20 mL of methanol at 0°C. The resulting mixture was refluxed for 2 h, cooled to room temperature and partitioned between 200 mL of methylene chloride and 200 mL of water. The aqueous layer was extracted with methylene chloride and the combined organic layers were washed twice with water, dried (K 2 Cθ3) and concentrated to give 0.6 g of a yellow solid. A solution of 0.5 g (0.002 moles) of the above product and 20 mL of THF was treated with a solution of 0.4 g (0.002 moles) 4-(trifluoromethoxy)phenyl isocyanate and 5 mL of THF. Two drops of water were added and the resulting solution was stirred at room temperature for 30 min. The reaction was then concentrated to give 0.90 g of slightly impure product that was used in the next step without further purification. An analytical sample was prepared by recrystallization from THF-hexanes, mp 233-235°C. -E NMR (200 MHz, dg-DMSO) δ 9.43 (s, IH) , 9.40 (s, IH) , 7.93 (d, IH), 7.78 (d, 2H) , 7.45 (apparent d, 3H) , 7.33 (d, 2H), ca. 3.67 (d, IH) , 3.66 (s, 3H) , 3.22 (d, IH) . Step C: Methyl 7-chloro-2.5-dihydro-2-r F T4-tri luoro- methoxy)phenyl1amino1carbonyl " .indenori r 2-el- TI,3r41pχadiazine-4a(3H)-carboxylate A mixture of 0.85 g (0.002 moles) of the product from Step B, 0.9 g of paraformaldehyde, 0.05 g of p-toluene sulfonic acid monohydrate and 50 mL of acetonitrile was heated at reflux for 1 h. The resulting mixture was cooled to room temperature and partitioned between CH C1 2 and saturated aqueous sodium bicarbonate. The aqueous layer was extracted with CH 2 C1 2 and the combined organics were washed with saturated aqueous NaHCθ3, dried (MgSθ4) and concentrated. The residue was purified by flash chromatography on silica gel using 4:1 hexanes-EtOAc to give 0.50 g of a pale yellow solid, mp 99-101°C. Trituration with hot hexanes gave a white solid melting at 126.5-128.0°C. IH NMR (200 MHz, CDCI3) δ 8.37 (br S, IH) , 7.66-7.50 (m, 3H), 7.35 (d, IH), 7.32 (s, IH) , 7.18 (d, 2H) , 5.92 (d, IH), 5.05 (d, IH), 3.73 (s, 3H) , 3.52 (d, IH) , 3.27 (d, IH) . Step D: Methyl 7-r ~ Moro-2.5-dihydro-2-r TN-methyl-N-f4- ftrifluoromethnxy)phenyl.1 amino1 arbonyl1- indenoTI.2-el n. . 1oxadiazine-4a(3H)- carboxylate A solution of 1.0 g (0.002 moles) of the product from Step C and 10.5 L of DMF was treated with 0.2 g (0.005 moles) of 60% NaH (in oil) at 0°C. After stirring for 10 min, 1.2 mL (0.02 moles) of iodomethane was added. The resulting mixture was stirred at room temperature for 2 h and then poured into ice-cold IH HCl and extracted with three portions of ether. The combined organics were washed with water, dried (MgSθ4) and concentrated to give a crude yellow solid which was triturated with methanol to give 0.70 g of a yellow solid, mp 130-131°C. ~-R NMR (200 MHz, CDCI3) δ 7.20 (apparent s, IH) , 7.16 (apparent s, 5H) , 6.84 (d, IH) , 5.29 (abq, 2H) , 3.67 (s, 3H) , 3.38 (overlapping d, IH and s, 3H) , 3.13 (d, IH) . Example 3 Step A: Methyl 2-amino-5-chloro-2. -di-hydro-l-oxo-lH- indene-2-carboxylate hydrochloride An ice cold solution of 11.4 g (100.8 mmol) of hydroxylamine-O-sulfonic acid in 102 mL of water and 50 L of sodium hydroxide solution (2N) was added in one portion to 10 g (102 mmol) of cyclohexanone in 180 mL of toluene and 50 mL of sodium hydroxide solution (2N) at 0°C. The mixture was stirred for 10 minutes. The organic layer was removed and dried over magnesium sulphate. Then, 7 g (31.3 mmol) of methyl 5-chloro-2,3- dihydro-l-oxo-2-lH-indene-2-carboxylate was added to a 155 mL portion of the solution; and 0.1 g (0.89 mmol) DABCO was then added in one portion to the mixture which was stirred for 1 h at 5°C. The mixture was washed twice with 50 mL portions of hydrochloric acid (IN) . The acid layer was evaporated under reduced pressure to give 4.37 g of a solid, m.p. 145 to 148°C (dec) . !H NMR (free base) (200 MHz, CDC1 3 ) δ 7.73 (d, IH) , 7.48 (s, IH), 7.41 (d, IH), 3.69 (s, 3H), 3.68 (1/2 ABq, IH) , and 3.05 (1/2 ABq, IH) . step B: Methyl 2-a inp-5-chloro-2,3-dihydrp-l-Ff \r-4- (tri luoromethoxy1phenyl.amino.carbonyll- hydrazonoT-lH-indene-2-carboxylate A mixture of 2 g (7.24 mmol) of the product from Step A and 1.83 g (7.78 mmol) of 4-(4-trifluoromethoxy)- phenylsemicarbazide in 18 mL of ethanol was boiled for 2 h. The mixture was allowed to cool and was stirred at room temperature overnight. The mixture was poured into 200 mL of saturated sodium bicarbonate solution and then extracted with 3 x 100 mL of ethyl acetate. The combined extracts were dried and evaporated and the material washed with ether to give 1.0 g of an off-white solid, of which a small portion was further purified by chromatography on silica gel (ethyl acetate/ethanol 5:1), m.p. 156.5 to 158°C (dec). NMR (200 MHz, CDCI3) δ 8.4 (s, IH) , 8.20 (s, IH), 7.83 (d, IH) , 7.56 (d, 2HJ, 7.42-7.18 (m, 4H), 3.73-3.65 (m, 4H), 3.05 (1/2 ABq, IH) . Step C: Methyl 2-amino-5-σhloro-2.3-dihydro-l-TT ϊT-4- (tri luoromethoxyϊphenyllaminoloarbonyll- hydrazpnol-lR-indene-2-carbpχylate A slurry of 0.12 g (6.48 mmol) of Eschenmoser's salt in 3 L of tetrahydrofuran was added to 0.3 g (6.57 mmol) of the product from Step B in 2 mL of tetrahydrofuran at room temperature. The mixture was stirred at room temperature for 65 h. The mixture was poured into 100 mL of saturated sodium bicarbonate solution and extracted with 3 x 50 mL of ethyl acetate. The combined extracts were dried and evaporated. Chromatography on silica gel (eluted with ethyl acetate/hexanes 1:1) gave 0.14 g of a white solid, m.p. 135° to 140°C (dec) . IR (mineral oil) : 3372, 3298, 1751, 1658, 1631, 1603, 1535, 1415, 1315, 1266, 1199, 1109, 1009, 967, 919 889, and 826 cm~ . IH NMR (200 MHz, CDCI3) δ 8.43 (s, IH) , 7.64-7.14 (m, 7H), 5.38 (1/2 ABq, IH) , 4.39 (1/2 ABq, IH) , 3.71 (s, 3H) , 3.53 (1/2 ABq, IH) , 3.08 (1/2 ABq, IH) , 2.40 (bs, IH) . By the general procedures described herein, or obvious modifications thereof, the compounds of Tables 1 through 72 can be prepared. In Tables 1 through 72 , the following notations have been used. Me «= CH 3 Et = CH 2 CH 3 n-Pr ~ = CH 2 CH 2 CH 3 i-Pr = CH (CH 3 ) 2 n-Bu - CH 2 CH 2 CH 2 CH 3 i-Bu - CH 2 CH (CH 3 ) 2 s-Bu = CH (CH 3 ) CH 2 CH 3 t-Bu - C (CH 3 ) 3 P O) ■ C COO ββ -- 0 o II II C0 2 (n-Pr) = C-0CH 2 CH 2 CH 3 C0 2 (i-Pr) «= C-0CH(CH 3 ) 2 O O II CO(t-Bu) - C-(CH 3 ) 3 C0 2 (t-Bu) - C-OC(CH 3 ) 3 CH 2 CCH — CH 2 C ~ =CH SN(i-Pr)C0 2 Et S— N C0 2 Et CO(4-Cl-P ) B ~ - B 3 X B 1 B 3 X CF 3 i-Bu C0 2 (n-Pr) CF 3 C0 2 Et C0 2 (n-Pr) CF 3 i-Bu C0 2 (i-Pr) CF 3 C0 2 Et C0 2 (i-Pr) CF 3 i-Bu CO(n-Pr) CF 3 C0 Et CO(n-Pr) CF 3 i-Bu CO(i-Pr) CF 3 C0 2 Et CO(i-Pr) CF 3 i-Bu CO(t-Bu) CF 3 C0 2 Et CO(t-Bu) CF 3 i-Bu C0 2 (t-Bu) CF 3 C0 2 Et C0 2 (t-Bu) 0CF 3 i-Bu C0 2 (n-Pr) OCF 3 C0 2 Et C0 2 (n-Pr) OCF 3 i-Bu C0 2 (i-Pr) OCF 3 C0 2 Et C0 2 (i-Pr) OCF 3 i-Bu CO(n-Pr) OCF 3 C0 2 Et CO(n-Pr) OCF 3 i-Bu CO(i-Pr) OCF 3 C0 2 Et CO(i-Pr) OCF 3 i-Bu CO(t-Bu) OCF 3 C0 Et CO(t-Bu) OCF 3 i-Bu C0 2 (t-Bu) OCF 3 C0 Et C0 2 (t-Bu) CF 3 C0 2 Me C0 2 (n-Pr) CF 3 Ph C0 2 (n-Pr) CF 3 C0 2 Me C0 2 (i-Pr) CF 3 Ph C0 2 (i-Pr) CF 3 C0 2 Me CO(n-Pr) <- F 3 Ph CO(n-Pr) CF 3 C0 2 Me CO(i-Pr) CF 3 Ph CO(i-Pr) ~~3 C0 2 Me CO(t-Bu) CF 3 Ph CO(t-Bu) CF 3 C0 2 Me C0 (t-Bu) CF 3 Ph C0 2 (t-Bu) OCF 3 C0 2 Me C0 2 (n-Pr) OCF 3 Ph C0 2 (n-Pr) OCF 3 C0 2 Me C0 2 (i-Pr) OCF 3 Ph C0 2 (i-Pr) OCF 3 C0 2 Me CO(n-Pr) OCF 3 Ph CO(n-Pr) OCF 3 C0 2 Me CO(i-Pr) OCF 3 Ph CO(i-Pr) OCF 3 C0 2 Me CO(t-Bu) OCF 3 Ph CO(t-Bu) OCF 3 C0 2 Me C0 2 (t-Bu) OCF 3 Ph C0 2 (t-Bu) OCF 2 H n-Pr CO(t-Bu) OCF 2 H C0 2 Me CO(i-Pr) OCF 2 H n-Pr C0 2 (t-Bu) OCF 2 H C0 2 Me C0 2 (i-Pr) OCF 2 H i-Pr CO(i-Pr) OCF 2 H C0 2 Me CO(t-Bu) OCF 2 H i-Pr C0 2 (i-Pr) OCF 2 H C0 2 Me C0 2 (t-Bu) OCF 2 H i-Pr CO(t-Bu) OCF 2 H CO^e CO(n-Pr) OCF 2 H i-Pr C0 2 (t-Bu) OCF 2 H C0 2 Me C0 2 (n-Pr) OCF 2 H i-Pr CO(n-Pr) OCF 2 H C0 2 Et CO(n-Pr) OCF 2 H i-Pr C0 2 (n-Pr) OCF 2 H C0 2 Et C0 2 (n-Pr) B x J X B x B 3 X CF 3 Me C0 2 (n-Pr) CF 3 n-Pr C0 2 (n-Pr) CF 3 Me C0 2 (i-Pr) CF 3 n-Pr C0 2 (i-Pr) CF 3 Me CO(n-Pr) CF 3 n-Pr CO(n-Pr) CF 3 Me CO(i-Pr) CF 3 n-Pr CO(i-Pr) CF 3 Me CO(t-Bu) CF 3 n-Pr CO(t-Bu) CF 3 Me C0 2 (t-Bu) CF 3 n-Pr C0 2 (t-Bu) OCF 3 Me C0 2 (n-Pr) OCF 3 n-Pr C0 (n-Pr) OCF 3 Me C0 2 (i-Pr) OCF 3 n-Pr C0 2 (i-Pr) OCF 3 Me CO(n-Pr) OCF 3 n-Pr CO(n-Pr) OCF 3 Me CO(i-Pr) OCF 3 n-Pr CO(i-Pr) OCF 3 Me CO(t-Bu) OCF 3 n-Pr CO(t-Bu) OCF 3 Me C0 2 (t-Bu) OCF 3 n-Pr C0 2 (t-Bu) CF 3 Et C0 2 (n-Pr) CF 3 i-Pr C0 2 (n-Pr) CF 3 Et C0 2 (i-Pr) CF 3 i-Pr C0 2 (i-Pr) CF 3 Et CO(n-Pr) CF 3 i-Pr CO(n-Pr) CF 3 Et CO(i-Pr) CF 3 i-Pr CO(i-Pr) CF 3 Et CO(t-Bu) CF 3 i-Pr CO(t-Bu) ~*3 Et C0 2 (t-Bu) CF 3 i-Pr C0 2 (t-Bu) OCF 3 Et C0 2 (n-Pr) OCF 3 i-Pr C0 2 (n-Pr) OCF 3 Et C0 2 (i-Pr) OCF 3 i-Pr C0 2 (i-Pr) OCF 3 Et CO(n-Pr) OCF 3 i-Pr CO(n-Pr) OCF 3 Et CO(i-Pr) OCF 3 i-Pr CO(i-Pr) OCF 3 Et CO(t-Bu) OCF 3 i-Pr CO(t-Bu) OCF 3 Et C0 2 (t-Bu) OCF 3 i-Pr C0 2 (t-Bu) OCF 2 H Me CO(n-Pr) OCF 2 H Et CO(i-Pr) OCF 2 H Me C0 2 (n-Pr) OCF H Et C0 2 (i-Pr) OCF 2 H Me CO(i-Pr) OCF 2 H Et CO(t-Bu) OCF 2 H Me C0 2 (i-Pr) OCF 2 H Et C0 2 (t-Bu) OCF 2 H Me CO(t-Bu) OCF 2 H n-Pr CO(n-Pr) 0CF 2 H Me C0 2 (t-Bu) OCF 2 H n-Pr C0 2 (n-Pr) OCF 2 H Et CO(n-Pr) OCF 2 H n-Pr CO(i-Pr) OCF 2 H Et C0 2 (n-Pr) OCF 2 H n-Pr C0 2 (i-Pr) A A A A A A A A A A A A A A A A A A A A A A A A A A A 04 04 0t 04 04 04 04 øt 04 øt 04 04 04 04 04 04 04 04 04 øt øt øt øt øt 04 øt øt I I I I I I I I I I I I I I I I I I I fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa I I I I I I I I I I I I I I I I I I ( 4 A A A A X! A A A A A A A A A A A A A A A A A A A A A A A 04 øt øt 04 04 0t 04 0t 04 øt øt øt øt øt 04 04 04 04 04 04 04 04 øt øt I I I I I I I I I I ϊ I I I I I I fa fa fa fa fa fa fa fa fa fa fa fa ϊ fa fa fa fa fa fa fa fa fa fa fa fa I I I I I I I I I I I I I I I I *-• <* i O Ω W Ω H TI H H to td It 2Φ 2Φ 2Φ Φ 2Φ Φ 2Φ 2Φ 2Φ 2Φ 2Φ 2Φ 2Φ if i φ? £ φ i φl i φ? 2 Φ 2 Φ 2 Φ 2 φ 2 φ to to TftBI-E 6 O O O O Q Ω W Ω O Ω W Ω Q Ω Ω tO Ω Ω Ω Ω Ω TI H H Ω TI H H ft TI o H H f-» Tl Tl Tl Tl Tl ω Tl to to to to to ω ω EC EB SB SB SE Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Q Q Q Q Q Q ft Ω ft ft Ω Ω Ω Ω Ω O O O O O O O O O O O O O O O O O O O O O .0 O .O .O O to -O to to to to -o to to to to to to to -O to to to to to to to to to to to 2Φ Φ2 2Φ Φ2 Φ2 Φ2 Φ2 Φ 2Φ Φ 2Φ Φ2 Φ Φ2 2Φ Φ2 Φ2 Φ Φ2 Φ2 2 2 Φ2 2Φ Φ2 2Φ Ω 3 td 2 SC Ω Ω Ω Ω Ω Ω Ω 3 3 3 3 Dd td H H 2 2 2 2 SS SB tE SB M 8 Φ •H« " φ 8 rt §rt §rt φ πφ gφ gΦ iH ϋH H Hi ' " rt ,t φ φ ' ' 8 O O Q O Q O Ω -O Ω Q Ω U ft Ω ft ft ft ft Tl Hu Ω Q Ω W Ω Q Ω W Ω Q Ω H Ω TI H H Ω T1 H H H H Ω TI H to Ti Ti Ti Ti Ti Ti Ti ω Tl ω τι ω τι ω P 8 Tl to to to to to to ω ω ω ω t 33 33 33 ~~t 33 »-C Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Q Q Q Q ft ft Q Q Ω Ω td O O O O O O O O O O O O O O O O O O O O O O O O O ω to to to to to -o to -o co -o to to to to to to to to to to t t t to to 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ φ Φ φ φ Φ φ φ Ω Ω Ω Ω Ω Ω Ω Ω ft ft O O ft ft ft ft ft ft O O SB EC 33 33 33 33 33 33 33 33 33 33 O .O O Dd to to to to to to fo to to to to to to to 8 to to to 8 to 8 to o _ to 8 Dd Dd td td 2 2 rt it rt rt φ φ n 0 ft ft Φ 8 Φ Φ 8 Φ if ϋ rt EC EC SB EC to to t to ft ft ft ft ft O ft ft ft ft ft ft ft ft ft ft ft O ft ft ft ft ft ft ft ft O o to ω ft ft ft ft ft ft ft ft ft ft ft ft O Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 33 ϊ-π 33 33 33 33 33 3-ι 33 PC 3* 33 33 33 33 33 ϊ-E 33 33 PC 33 33 33 33 33 33 33 to t to to to to to to to to t to to to to to to to to to to to -o to to io to to SE Ω Ω Ω Ω Ω Ω Ω 3 3 3 3 td td td Dd 2 2 2 2 SS EE SB EC it It φ φ φ φ § H § 8 8 8 8 r d 'd "d 'd t+ r+ rt rt rt φ φ φ φ H H H H ft ft ft ft ft O O Q O O ft ft SE S SC SE SS EC EC SS ES SB SB EB t to to to to to to to to to to to ft ft ft ft SE SE EC O to to to to to 8 to 8 to 8 to 8 to 8 to 8 to 8 8 Dd * Dd td td § § § It It rt r? ϋ I * I rt TABLE 7 t« o ft gft gft oΩ Ωo oTI wH ft H Ωg ftTI wH o H oΩ ftTI wH o H oΩ ftTI wH ft H gΩ ftTI wH ft H gΩ nTI roH o H to H τι τι τι τι τ ω τι ω τι ω τι ω τι ω τι ω to to to to to ω ω ω ω ω 03 PC 33 ϊ-G 03 ft ft ft ft ft ft O ft ft O ft ft ft ft O ft ft ft ft ft ft ft ft O ft ft ft ft tO O O O O O O O O O O O O O O O O O O O O O O O O O O O O ω to to to to to M to to -o io to to to to M io to to to to to to -o to -o to to -o 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ O EE Ω ft ft ft ft tf 0 3 3 3 3 Dd td td Dd 2 2 2 O O O Q Q Q Q I I I I rt rt rt rt i» Φ Φ « td td 2 2 2 2 , d , d O , « ϋ SE SB EE H rt rt rt φ φ φ φ H H H H o g o g o g o Ω u Q ro Ω g Ω ro Ω Ω ro u Ω h-J ft tij ft rtj ft >»J O fι| ft iι| ft htj j T H ft ft jl H ft Tl H H ft Tl H H TI H H τι ω T! TI ω to to to to to to ω ω ω ω PC PC 03 33 C PC Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω O O O O O O O O O O O O O O O O O O O to to to to to to to to to to to to to to to to to ro to 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 - - Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ if if Φ Φ Ω Ω Ω Ω M EB SB SE SS to to to to 8 Φ 8 8 Φ 8 Φ ft ft ft ft ft ft ft ft ft ft ft ft ft ft ft ft ft ft ft ft ft ft o ft ft o π ft td ω ft ft ft ft ft ft O O O ft ft ft ft ft ft ft O ft ft ft ft ft O ft ft ft ft ft 33 33 03 33 33 PC 33 33 PC 33 33 33 33 03 33 PC 33 33 PC PC 03 PC PC P PC 03 03 PC to to to to to to to to -o to to to io -o to to to to to to to to to to -o to to fo SB SB H W Ω g Ω W Ω g Ω W Ω g Ω W Ω g Ω W Ω O tβ H H Ω TI H H Ω TI H H ft TI H H ft TI H H Ω H τι ω τι ω τι ω τι ω τι ω ω ω ω ω ft ft o ft ft ft ft ft ft o π o ft ft ft ft ft o ft ft ft ft ft o ft ft o to ω ft ft ft ft ft ft ft ft ft ft O ft ft ft ft ft SB EC EC EC is sc !S SC SB SS SS SE SS SB SE EE ft 03 o PC n PC o 03 ft 03 o 33 o PC n PC o 03 to t t t to to to t to t to t to to to to t tO t N) t ) tO t tO B 1 B 3 X CF 3 i-Bu C0 2 (n-Pr) CF 3 i-Bu C0 2 (i-Pr) CF 3 i-Bu CO(n-Pr) CF 3 i-Bu CO(i-Pr) CF 3 i-Bu CO(t-Bu) CF 3 i-Bu C0 2 (t-Bu) OCF 3 i-Bu C0 2 (n-Pr) OCF 3 i-Bu C0 2 (i-Pr) OCF 3 i-Bu CO(n-Pr) OCF 3 i-Bu CO(i-Pr) OCF 3 i-Bu CO(t-Bu) OCF 3 i-Bu C0 2 (t-Bu) CF 3 C0 Me C0 2 (n-Pr) CF 3 C0 2 Me C0 2 (i-Pr) CF 3 C0 2 Me CO(n-Pr) CF 3 C0 Me CO(i-Pr) CF 3 C0 2 Me CO(t-Bu) CF 3 C0 2 Me C0 2 (t-Bu) OCF 3 C0 2 Me C0 2 (n-Pr) OCF 3 C0 2 Me C0 2 (i-Pr) OCF 3 C0 2 Me CO(n-Pr) OCF 3 C0 2 Me CO(i-Pr) OCF 3 C0 2 Me CO(t-Bu) OCF 3 C0 2 Me C0 2 (t-Bu) OCF 2 H n-Pr CO(t-Bu) OCF 2 H n-Pr C0 2 (t-Bu) OCF 2 H i-Pr CO(i-Pr) OCF 2 H i-Pr C0 2 (i-Pr) OCF 2 H i-Pr CO(t-Bu) OCF 2 H i-Pr C0 2 (t-Bu) OCF 2 H i-Pr CO(n-Pr) OCF 2 H i-Pr C0 2 (n-Pr) χ&BIι£_2 B 1 B 3 X CF 3 4-F-Ph COEt CF 3 4-F-Ph C0 2 Et CF 3 4-F-Ph CO(n-Pr) CF 3 4-F-Ph CO(i-Pr) CF 3 4-F-Ph CO(t-Bu) CF 3 4-F-Ph n-Pr OCF 3 4-F-Ph COEt OCF 3 4-F-Ph C0 2 Et OCF 3 4-F-Ph CO(n-Pr) OCF 3 4-F-Ph CO(i-Pr) OCF 3 4-F-Ph CO(t-Bu) OCF 3 4-F-Ph n-Pr CF 3 C0 2 Me COEt CF 3 C0 2 Me C0 2 Et CF 3 CO^e CO(n-Pr) CF 3 C0 2 Me CO(i-Pr) CF 3 C0 2 Me CO(t-Bu) CF 3 C0 2 Me n-Pr OCF 3 C0 2 Me COEt OCF 3 C0 2 Me C0 2 Et OCF 3 C0 2 Me CO(n-Pr) OCF 3 C0 2 Me CO(i-Pr) OCF 3 C0 2 Me CO(t-Bu) OCF 3 CO^e n-Pr OCF 2 H n-Pr H OCF 2 H n-Pr Me OCF 2 H n-Pr Et OCF 2 H n-Pr n-Pr OCF 2 H n-Pr COMe OCF 2 H n-Pr C0 2 Me OCF 2 H n-Pr COEt 0CF 2 H n-Pr C0 2 Et TABLE 12 191 TAB E 13 co co co co co co co co co co co co co co co fa l-- . ---i k . E--i co co co co co fa fa fa fa fa § H fa fa fa fa fa ø3 O O O O O 8 8 8 8 B B B B B 8 8 8 8 8 i TAS E 16 » * M M M M M M M M M M øt øt øt øt øt øi øt øi øt CO 4J -P -P -P 4-I 4J 4-1 4-I 4-I 4J I 1 I I I I I I I I 4J 4J 4J 4J ø3 H H H H fa fa fa H fa H C G G G G G C G C G fa fa fa fa fO CO CO CO CO fO CO fO CO fO CM CM CM CM ON CO CO CO CO CO fa fa fa fa fa CO CO CO CO CO fa fa fa fa fa fa fa fa fa 3 Ϊ-3 B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 8 8 8 8 ON i • • co co to co co o CO CO CO CO CM CM CM CM CM CM CM CM CM CM CM co co to co co fa fa fa fa fa co co co co co fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa H 03 fa0 fa0 fa0 fa0 fa0 g0 g0 g0 g0 g0 fa0 fa0 fa0 fa0 fa0 g0 g0 g0 g0 g0 g0 g0 g0 g0 g0 g0 g0 o0 g0 g0 υ0 2 Φ £ a O o sc a Φ 4wJ Oυ 8 o PO" as CO CO CO CO CO CO CO CO CO CO CM CM CM CM CM CM CM CM CM CM CM CO CO CO CO CO fa fa fa fa fa CO CO CO CO CO fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa § ø3 B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 ε. i 3 EC co co co co co co co co co co co co cM co co co co CO . co fa fa fa fa fa fa co co co co co co fa fa fa fa fa fa fa fa fa fa fa fa fa g g g g o o fa fa fa fa fa fa o o g g o g o in ø3 O O O ϋ O O O O O O O O O O O O O O O O O O O O O oM o φ φ φ φ φ φ φ φ φ φ φ φ φ φ φ φ φ φ φ φ a CM aCM a-M aCM a-M aCM aCM a-M aCM a-M aCM a-M a CM aCM aCM aCM aCM aCM aCM aCM m O O O O O O O O O O O O Φ 2 O O O O O O O O 03 o o o o o o o o o o o o a O O O O O O O O rO fO CO CO rO CO CM CM CM CM CM CM CM CM fco fco co afco co co fa fa fa fa fa fa fa fa fa fa fa fa fa fa 0a 0a 0fa 0 0fa 0fa o0 o0 o0 o0 o0 o0 o0 o0 o0 o0 o0 g0 o0 o0 ON I » • (1 ) 4 ) 4* 4- 4- 4. 4- 4- + ) 03 U U fa U H H fa » co co co co co ro co co ro fO CM CM CM CM ON co co co co co fa fa fa fa fa CO CO CO CO CO fa fa fa fa fa fa fa fa fa H Λ fa fa fa fa fa g g g g g fa fa fa fa fa g g g g g g g g g rt o o o o o o o o o o o o o o o o o o o o o o o o i 3 § ~i CΛ 1-3 41 fa H 8 as co co co co co co co co co co co co CM co co co co co O fa fa fa fa fa fa co co co co co co fa fa fa fa fa fa fa H fa fa fa fa fa fa g g g g g o fa fa fa fa fa fa g g g g o g g o. 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 o CM co co co co co co CO CO rO tO CO fO CM CM f fa fa co co a co o co fa fa a fa co co co fa fa fa fa fa fa fa fa faCM faCM faCM faCM faCM f faCM co co co ø3 υfa υfa υfa o υfa ofa oo gδ υo υo go oo faυ faυ υfa ofa ofa fao oo oo oo oo oo go oo oo oo oo go oo oo oo i • * ø3 fa fa CO CO CO CO CO CO CO CO fO CO CM CM CM CM ON co co co co co fa fa fa fa fa co co co CO co fa fa fa fa fa fa fa fa fa 3 ø B B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 8 8 8 8 S i 3 τ-n ON 41 41 41 41 41 fa fa fa fa fa CM CM CM CM CM co o -c xi xi xi xi xi xi xi xi xi xi xi o q o o o 03 0t 0! 0! 01 01 01 01 0! 01 0| 0! 0! θ O O O O EC co co co co co co co co co co co fa CO fa co fa co fa co fa co fa CcOo fafag fao fag fag fag fafaυ faO CO CO to CO co fa fa fa fa fa fa fa rt ro ø3 υ υ υ υ o υ o o o o o o o ofa ofa υfa υfa υfa oo go go oo go go oo rH as as sc as o. co co co co co CM CM CM CM co co co co co co fa fa fa fa fa fa co co co co co co fa fa fa fa fa fa fa fa fa fa fa fa fa fa 3 rt fa fa fa fa fa fa g g g o υ g fa fa fa fa fa fa g o υ υ υ υ υ o o g o o o o 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON i ** 3 ON CΛ xi 01 B M 01 2 fa CO φ 41 41 øi a fa 2 fa 8 I «* fa fa fa fa fa fa fa I I I I I vo vo «o vo vo vo vo co co co co co co co co co co ON fa CO fa CO fa CO fa CO fa CO gfa gfa gfa fag fag fa CO faCO fafO faCO fafO gfa gfa fag fag fag 03 o υ o o υ δ o o o o υ o υ o o o o o o o ON i B x B^ B 3 CF 3 7-C1 Me CF 3 7-C1 Et CF 3 7-C1 n-Pr CF 3 7-C1 C0 2 Me CF 3 7-C1 4-F-Ph OCF 3 7-C1 Me OCF 3 7-C1 Et OCF 3 7-C1 n-Pr OCF 3 7-C1 C0 2 Me OCF 3 7-C1 4-F-Ph CF 3 7-F Me CF 3 7-F Et CF 3 7-F n-Pr CF 3 7-F C0 Me CF 3 7-F 4-F-Ph OCF 3 7-F Me OCF 3 7-F Et OCF 3 7-F n-Pr OCF 3 7-F C0 2 Me OCF 3 7-F 4-F-Ph TABI-E 22 H 3 ON O ON CΛ Xi 3 01 I fa I <» rH rH rH rH rH rH rt υ υ υ o o o o CM I I I I I I I ø3 vo o to to to to to co co co co co co co co co co CO CO fO CO CO fa fa fa fa fa C r C0 CO C0 fa fa l--ι fa l--ι fa fa fa fa fa υ υ o o o fa fa fa fa fa o o o o o 03 o υ υ o υ o o o o o o υ υ o υ o o o o o CM ON I TABLE 26 C(0)Me / TRRT-T- 28 co co co co o co co co co co ON co o co co co fa fa fa fa fa co co to co o fa fa fa fa fa ø B B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 CM ON § 3 τ-~ ON © ON CΛ 3 4J H O fo co fo co co co co co co ro co co rH fa co fa co fa co fa co fa co - a co gaf g fa fa fa fa o fa fa fa fa fa fa in 03 0 0 0 0 0 0f 0 0 g0 o fa 0 g0 o0 fa co 0 0afco faco 0 faco co c 0 fa0 fa0 g0 0g g0 o0 g0 0o M CM 4J H O ON -- (-3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ON CO 4-1 4 ) 4-1 4-» 41 03 fa fa fa fa fa CO CO CO CO O co co co co co o. CO CO CO CO CO fa fa fa fa fa O O CO CO CO fa fa fa fa fa o3 B B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 CM ON i 3 ON ON CΛ co co co co co co co co co co co ro co co co co co co fa fa fa fa fa fa co co co co o fa fa fa fa fa fa TH fa fa fa fa fa fa o o g g o o fa fa fa fa fa fa g υ g g g g I s - 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM CM to -p 03 fa co co ro co fo co fo co fO fo co co ON co co co co co co fa fa fa fa fa fa co co co co co co fa fa fa fa fa fa rt fa fa fa fa fa fa o o o o υ υ fa fa fa fa fa fa o o o o o o 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ON I » » 3 § ON 3 6 ft. co co co co co co co co co co ON co co co co co fa fa fa fa fa co co co fo co fa fa fa fa fa o B B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 CM ON I 3 ON CΛ P B ft. a. M CM M M M M M M M M M M M Ot Ot øi Ot øt Ot 04 Ot CM øt Ot 41 41 4> 41 4-1 41 41 41 41 4-1 I I I I I I I I I I I 03 fa fa fa W fa fa fa fa fa fa fa ϋ G c c G C c c G G G G G co co co co co co co CO CO CO O o ON co co co co co co fa fa fa fa fa fa co o co co co co fa fa fa fa fa fa •H fa fa fa fa fa fa υ g υ υ g o fa fa fa fa fa fa g υ υ υ υ g 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O % • * »« • 3 s CΛ 5 ft, co co co co co a o B B B B CM i 3 •-■ ON © CΛ co co co co co co co co co co co co co co co co co co fa fa fa fa fa fa co co co co co co fa fa fa fa fa fa ΓH fa fa fa fa fa fa g g g g υ o fa fa fa fa fa fa g g υ υ υ υ 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 co CM 4» fa O H O CO 4-> 03 fa co co co fo co co co co co co co co ON co co co co co co fa fa fa fa fa fa co co co co co co fa fa fa fa fa fa τH_ fa fa fa fa fa fa O O O O O O fa fa fa fa fa fa O O O O O O rM 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON I •« • H EC 2 -I £ a & a £ a £ a £ £ £ £ CM CM CM CM CM. CM aCM aCM. aiM aCM CO q o Q o q o q o q q xi xi xi xi xi xi ø3 0 0 0 0 0 0 0 0 0 0 øι ø! øι øι øι øι øι ø! 0! øι co co co co co CO CO O CO CO ON CO O CO CO O fa fa fa fa fa co co o ^ co co fa fa fa fa fa ,-i fa fa fa fa fa g g g g g fa fa fa fa fa g g g g g 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON i (R 2 is Cl) * • Φ £ a Φ £ a 4i o o 1 41 8 θ" H EC $ » o υ sc a fa o υ xøiι øt ON co co co co co co co 3 r-i fa fa fa fa fa o3 υ o o o o B B CM ON I CO M a Φ aΦ aΦ aΦ aΦ a41 aΦ aΦ aΦ aΦ Φ Φ CM CM CM CM CM CM CM CM CM CM aCM aCM co O O O O O O O O O O O O Xi i Xi Xi Xi Xi o3 o o υ o o o o o o o o o ot Ot Ot 0ι Ot Ot co co co co co co co co co co co co co co co co ON co fa fa fa fa faco faco faco faco co fa g g o υ υ fa g fa co to to co fa fa fa fa fa fa co g fa υ fa fag o fa fao g fa co co fa fa fa fa fa fa o g o o fa co fa co 3 T fa 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON 0 * * co co co co co co co co co co co co co co co fa fa fa fa fa co co co co co fa fa fa fa fa 3 ø3 B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 CM ON i 3 ON © ON CΛ a. n CM -- -- -- - -- H CM 2 CM CM 2 CM co XS -G xi X! O O O O Xi xi -G xi 03 0i 0i 0i Ot O O O O Ot 01 01 øt co to co co to to co co co co co 10 co co co co fa fa fa rH fa fa fa fa fa fa y o g o fa o fa o fa co co co f fa fa co a ON a o fa fa co fa O fa o f o fa o fa fa co fa co 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON • • ►* • 3 3 ON CΛ 3 co A 03 0ι øι co co co co co co co co co co ON co co co co co fa fa fa fa fa co co co co co fa fa fa fa fa o3 B B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 CM ON i 3 ON - - m -- --- -- ON CΛ CM -- -- -- - -- -- 41 H § O Φ Φ Φ Φ Φ 4) Φ Φ Φ 4) Φ Φ a CM aCM aCM aCM aCM aCM aCM aCM aCM aCM aCM aCM O O O O O O O O Q O O O O -C -C -G -G -G -G -G ' XS Xi ø3 O O O O O O O O O O O O Ot Oi Ot Ot øi øi Oi Ot øi Ot Ot co co co co co co co co co co co co co co o co co co co co co ON co fa fa fa fa fa fa co co co co co fa fa fa fa fa fa co o fa fa fa fa co co rt fa fa fa fa fa fa g g g o o o fa fa fa fa fa fa o o o o g o fa fa o g g o fa fa CM 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON § • • &a £ £ £a & £ £ £ M a £ £ C -M aCM CM aCM aCM aCM aCM aCM aCM co q q q q q q q o o q xi -c xi Xi XI 03 θ O O O O O O O O O 0t øι 0ι øι øt 0ι øι øt Oi ØI co co co co co co co co co co ON co co co co co fa fa fa fa fa fO fO fo ro co fa fa fa fa fa 3 o3 B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 i 3 co co co co co co co co co co co o co co to co CO CO CO CO co fa fa fa fa fa fa co co co CO co co fa fa af fa fa fa co co fa fa co co fa fa rt ^ fa fa fa fa fa fa g o g g g o fa fa fa fa fa fa g g g g g o fa fa g υ fa fa g o 00 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 tf CM 1 H § O Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ a a a a a a a a a a a a £ a £ a £ a £ a xn Q Q Q qo qo Qo Q. q xi xi xi xi xi xi O O O O X! xi xi X! o3 o o o o o qo q xi xi xi o qo qυ Λ xi ot θι 0ι CM øt øt øi Ot Ot øi Ot O O O O Ot Ot 04 Ot co co co co co co co co co co co co co co co co co co co co fa fa fa fa fa fa co co co co co ON co fa fa fa fa fa fa co co fa fa fa fa co to ■ v •H fa fa fa af fa fa o υ o o g υ fa fa fa fa fa fa υ o o υ y υ fa fa o o o o fa fa CM 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 U O O O O O O O O O O O O O O O CM ON i » • »« • C co co co co co co co co co co ON co co co co co fa fa fa fa fa o co co co co fa fa fa fa fa o3 B B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 S. § 3 ON CΛ co co co co co co co co co co to co co co co co O CO CO CO CO C cOo fafa -. fafa fafa fafa fafa fafa co co co co co co fa fa fa fa fa fa co co fa - - - fa - co co - t ^ fa fa f a fa o y y υ y fa fa fa fa fa P-. y y y y y y fa υ f- a fa f y fa o y fa fa yaf. . r a lO 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 q* CM - --- -- -- -- - - - -- -- -- Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ a CM aCM aCM aCM aCM aCM aCM aCM aCM aCM aCM aCM CO o o o o o o o o o o o -G xi xi xi xi xi 03 O O O O O O O O O O O O CM CM CM CM Oi CM CM Oi CO to to co co co ON CO CO CO CO CO CO fa fa fa fa fa fa co co co co co co CO CO rt fa fa fa fa fa fa g g g o o g fa fa fa fa fa fa fa fa 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON i H EC 2 o o oo oυ oo oo oo oυ oo oo xosi xoii Xi Xi Xi Xi Xi Xi Xi Xi to CO CO CO O CO CO O CO O ON CO CO CO co co fa fa fa fa fa CO CO CO CO co fa fa fa fa fa o B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 CM ON s 3 ON © ON CΛ 3 CO CO co co co co co co o co co to co co co co CO CO CO CO CO co fa fa fa fa fa fa co co fa fa fa fa fa fa to co fa fa co co fa fa -H fa fa fa fa fa fa g g g O O g fa fa fa fa fa fa g g g O O g fa fa O O fa fa O O r- 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 φ φ φ φ φ φ φ φ φ φ φ φ a CM aCM aCM aCM aCM aCM aCM aCM aCM aCM aCM aCM co ^ O O O O O O O O O O O O Xi XS 03 0 0 0 0 0 0 0 0 0 0 0 0 04 01 co co co co co co co to to co co co co co co co ON co co co co co co fa fa fa fa fa fa co co co co co CO fa fa fa fa fa fa co co fa fa fa fa co co 3 rt fa fa fa fa fa fa g g υ o o o fa fa fa fa fa fa o o υ υ υ o fa fa g o g o fa fa 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM I co co co co co co co co co co ON CO O O CO CO fa fa fa fa fa CO fa fa fa fa fa 3 ø3 B B B B B 8 8 8 8 8 B 1 B B B B 8 8 8 8 8 3 i 3 - s ON CΛ 3 co co co co co co co to co co co co co co co co co fa fa fa fa fa fa co co co co co co fa fa fa fa fa H fa fa fa fa fa fa g g o υ g υ fa fa fa fa fa fa g o o o g 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 x-l* CM 4J H 5 O A A A A A xi xi xi xi Ot øt øt øt øt øt Ot øt Ot co co co co co co co co co co fo co co co co co ON co co co co co fo fa af fa fa fa fa co co co co co co fa fa fa fa fa fa co co fa fa fa fa * rt fa fa fa fa fa fa g o o o g g fa fa fa fa fa fa o o o o o g fa fa o g g g fa fa CM 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ε. § 3 τ-n φ φ a CM a C a φ φ M CM a CM P P q q xi o O Ot CO CO CO CO CO co co co co co ON rt fa co faco faco faco faco yfa gfa gfa fag ϋfa fa co faco f aco faco faco gfa gfa fag fag fag 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 § 3 ON CΛ 3 rH lO CM - -» -- ■- - -- -- φ φ φ φ φ φ φ φ φ φ φ φ a CM aCM aCM aCM aCM a-M aCM aCM aCM aCM aCM aCM to O O O O O O O O O O O O xl xi xi xi xi xi xi 03 0 0 0 0 0 0 0 0 0 0 0 0 0; Ot øt ø t Ot Ot O t co co co fo co co co fo co co co co co co co co ON co co co co co co fa fa fa fa fa fa co co co co co co fa fa fa fa fa fa co co fa fa fa fa co co rt 03 0fa 0fa 0fa fa0 0fa 0fa o0 g0 g0 o0 o0 o0 0fa 0fa 0fa 0fa 0fa 0fa g0 o0 g0 o0 g0 o0 0fa 0fa o0 υ0 g0 o0 0fa fa0 CM ON I • • •* » a 4) 4> Φ Φ Φ 4) Φ Φ Φ Φ CM aCM aCM aCM a-M aCM aCM aCM aCM aCM C0_ P O P P o p p p q p xs O3 O O O O O O O O O O OI 04 co co co co co o co co co co ON co co co co co fa fa fa fa fa co co co co co fa fa fa fa fa 3 o B B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 CM ON § 3 ON © ON CΛ 3 o 10 CM -- -- -- § φ Φ 4 ) C.M i Φ CM ϊ^ CM CM 2 CM 2 CM 2 CM 2 CM a CM a CM a CM a CM ό O O O O O O O -G Xi Xl XS XS Xi Xi Xl Xl Xi Xi Xl O O O O XΪ Xi Xl Xi O O O O O O O O Ot Oi Oi Oi øt Oi Oi Ot Oi Ot Oi Oi O O O O Ot Oi Oi Oi co co to to co co co co co co co co co co fO fo ON co co co co to fa fa - fa fa fa fa to co co to co tcoo fafa fafa fafa fafa fafa fafa ccoo ccoo fafa fafa fafa fafa co co 3 rt fa fa fa fa fa fa g g g g g g fa fa fa fa fa fa o g o υ υ o fa fa g g g g fa fa --3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON I • • •» * CO « v xi χi χs xi χi xi xi xi xi χi 03 C-t øt øt 04 0t øt øt 0ι 0ι 0ι ON co co co co co co co co fO fo co co co co co fa fa fa fa fa co co co co co fa fa fa fa fa o B B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 S. § 3 co co co co co co co co co co co co CO CO co co CO CO CO CO co co fa fa fa fa fa fa CO CO CO CO CO CO fa fa fa fa fa fa CO CO fa fa CO CO fa fa H fa fa fa fa fa fa g g g g o o fa fa fa fa fa fa g g g g g g fa fa o g fa af g g in 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 m CM a CM aCM aCM aCM aCM aCM aCM aCM aCM aCM aCM aCM co O O O O O O O O O O O O Xi Xi X! A A A A A A A A 03 0 0 0 0 0 0 0 0 0 0 0 0 01 Ot øt ø l øl øl øl ø l øl ø l øt co co co to co co co co co co co co CO CO CO to ON co co to co co to fa fa fa fa fa fa to co to co co fa fa fa fa fa fa co co fa fa fa fa co co CM TH fa fa fa fa fa fa g g g g υ υ fa fa fa fa fa fa g g g o g g fa fa g g o o fa fa 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON § •* • £a £a £a £a £a £a £a £ £ £ CM CM CM CM CM CM CM aCM aCM aCM CO p q o p o q q p Q O x: xi xi 03 O O O O O O O O O O 0t 0ι 0t øt 0ι 0ι 0ι øt 0ι øι I CO CO CO CO CO o co co co co co co co co co fa fa fa fa fa co co co co co fa fa fa fa fa o3 B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 s % 3 ON ON CΛ m CM 41 H O co 03 ON to co co co co co co co co co co fa fa fa fa fa fa to rt ^ fa fa fa fa fa fa g g o o o o fa 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON I fc.* • oo a Φ aΦ a4> a4) aΦ aΦ aΦ aΦ a4) a4) CM CM CM CM CM CM CM CM CM CM to oO Oo Oo Oo Oo Oυ Oo Oo Oo Oo .SG ON co co co co co o co co co co •H fa co faco faco faco faco ofa fag gfa ofa gfa fa co faco faco faco faco fag gfa fag gfa yfa 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON I 3 ON © ON CΛ 3 σ. 2 CM 2 CM 2 CM a CM 2 CM 2 CM 2 CM CM 2CM 2 CM 2 CM 2 CM 2 CM CO O O 8 O Xi A Xi Xi -G xi xi xi x: xi A A O 03 O o Oo 8 8 8 O O ϋ CM Ot Oi 04 Oi 01 Ot øt 04 øt øt øt 8 o 8 8 i i xi xi Ot 04 Ot CM to co co co co co co co co co co co to co co co co co co co co fa fa - fa fa- - fa- - afa fafa fafa fafa fafa fafa co co fa fa fa fa rt3 0fa 0f fa- co co co co co ccoo f a 0fa fa0 0fa fa0 y0 g0 o0 0o g0 o0 fa0 0fa fa0 fa0 0fa 0fa o0 o0 o0 0o o0 o0 0fa 0fa o0 o0 o0 o0 0fa co fa co 0 0 CM ON 3 © ON CΛ co to co co co co to co co co co co ro to co co co co co co co co fa fa fa fa fa fa co to co co ro co fa fa fa fa fa fa ro fa fa co co fa fa TH fa fa fa fa fa fa o g g o o o fa fa fa fa fa fa o g υ g o o fa fa o g fa fa υ g 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 VO CM co C^ rt 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM I *• • co ON o co co co co co co co co co co co co co co fa fa fa fa fa co co co co co fa fa fa fa fa o3 B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 CM ON I 3 ON CΛ 3 B ft. CO VO CM - -- -- -- - - -- -- -- --- ON 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON § »* 3 S ON CΛ 3 Φ Φ Φ Φ 4) 4) Φ Φ Φ Φ a CM, a-M aCM aCM aCM aCM aCM CM a-M aCM co_ q q o o o q q q q q -G xi x; xi x: 03 O O O O O O O O O O 0ι 0ι 0t øt 0ι 0t øt 0ι Ot Ot CO CO co co co co co co co co CO CO CO O O fa fa af fa fa CO O CO CO CO fa fa fa fa fa r fa fa fa fa fa g g g g g fa fa fa fa fa g g g g g 03 0 0 1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON I 3 ON © ON CΛ 3 co co co co co co co co co co co co co co co co CO fO CO CO CO co fa fa fa fa fa fa co co co co co co fa fa fa fa fa fa co co fa fa o co fa fa - fa fa fa c m 0i3 0fa 0a 0fa 0 0fa 0fa y0 g0 g0 o0 g0 0o 0fa 0 0 0fa 0fa 0fa g0 g0 g0 g0 g0 g0 0fa 0fa g0 y0 0fa 0fa 0 g0 o M H a Φ 4> Φ 4 ) CM a CM a CM a CM CO Xi X! O O O O XI x: xi x: øt CM O O O O CM Ot Ot CM ON co co co to co co to co co co co co co co co co co co co co co co fa fa fa fa fa fa co co to co co co fa fa fa fa fa fa co to fa fa fa t -H fa fa fa fa fa fa g g g g g g fa fa fa fa fa fa o o o o o o fa fa g o g g fa o co fa fa 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 M ON I «• 3 § ON CΛ 3 co Xi 03 S ON a co co co co co CO CO CO O CO fa fa fa fa fa r-i fa fa fa fa fa g g g g g fa 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON I 3 ON CΛ 3 t- vo M -- -- - - H 03 ON CM rt 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON I w» » 3 ON s Bft, H sc £a £a £a £ £ & £ £ CM CM CM aCM aCM. aCM aCM aCM CO.. q q q q q q q q 03 O O O O O O O O ON CO CO CO O CO CO CO O fa fa fa r-i fa fa fa fa fa y g o 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 i 3 ON -- -- -- -- - - - CΛ 3 co co to co co co co co co co co ro co co to co co to co co co co fa fa fa fa fa fa co co co co co co af fa af fa co co fa fa co co fa fa rt fa fa fa fa fa fa g g o g g g fa fa fa fa fa fa g g g fa fag g o fa fa g o fa fa o o σi 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 vo CM xn Xi Xi xi xi xi xi xi -G xi XI øi CM Ot Ot Ot øt Ot øt Oi CM ON 3 co co co co to to co co to co co co ro co co ro co co co co co ro fa fa fa fa fa fa to to to co co to fa fa fa fa fa fa co co fa fa fa fa to to i-t fa fa fa fa fa fa y g g o g υ fa fa fa fa fa fa o o o o o o fa fa o o y o fa fa 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON % 3 ON CΛ 3 ON O CO CO CO CO CO CO CO CO CO CO CO CO CO CO fa fa fa fa fa C0 C0 C0 C C0 l--ι fa fa fa fa ri fa fa fa fa fa y g o g g fa fa fa fa fa y g g g g 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM § 3 ON --- ---- -- - -- -- - --- CΛ 3 t-l r- CM - -- - -- - -- - -- - x* CM 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON I *»» £a £a a£ £a £a £a £a £a £a £ CM CM CM CM CM CM CM CM CM aCM co o o o o o o o o σ o xs ø3 0 0 0 0 0 0 0 0 0 θ S ON CO fO CO CO CO co co co co co co co co co co fa fa fa fa fa co co co co co fa fa fa fa fa o3 B B B B B 8 8 8 8 8 B B B B B 8 8 8 8 8 CM ON % 3 ON CΛ 3 o 0 co co co co co co cO fO fo co co co co co co co co co co co co co fa fa fa fa fa fa co co co co co co fa fa fa fa fa fa co co fa fa co co fa fa rt ^ fa fa fa fa fa fa o g o o o o fa fa fa fa fa fa o g g g o g fa fa o g fa fa o g O 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 r- M - - - H φ φ φ φ Φ Φ Φ Φ Φ Φ Φ 4) a CM a CM a CM a C .M aCM aCM aCM aCM aCM aCM aCM aCM co O O O O " q q q o o o o o -c 03 O O O O O O O O O O O O Ot co co co co co co co co co fo co to co to co co fa fa fa fa fa fa co co fa fa fa fa co to fa fa fa fa fa fa o o o o o o fa fa o g o g fa fa 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 § TABLE 54 Y (R 6 is H) 3 ON ON CΛ 3 H EC SC 2 SS -H ON x* CM r 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON § 3 S CΛ 3 H as x CM -- 03 0 0 0 0 U O O O O O O O O O O O O O O O CM ON i *• * 3 ON CΛ 3 B H EC s co co co co to co co co co co co co co co co fa fa fa fa fa co co co co fa fa fa fa fa TH fa fa fa fa fa g o g υ g fa fa fa fa fa y g g g g 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CM ON % TABLE 59 TABT.1-- 60 (R 2 is Cl, R 3 is C0 Me) E 1 ϊ CF 3 CH 2 SiMe 3 CF 3 CH 2 CF 3 CF 3 CH CCH CF 3 CH 2 C0 2 Mβ CF 3 CH 2 CN CF 3 i-Pr CF 3 Ph CF 3 4-Cl-Ph CF 3 4-OMe-Ph CF 3 4-F-Ph CF 3 t-Bu CF 3 CH 2 SOCH 3 CF 3 CH 2 S0 2 CH 3 CF 3 SN(i-Pr)C0 2 Et CF 3 SN(Me)C0 2 Et CF 3 SN(n-Bu) 2 CF 3 S (Me)C0 2 (n-Bu) CF 3 SN(i-Pr)C0 2 (n-Bu) CF 3 SN(i-Pr)C0 2 (n-Pr) CF 3 n-Bu CF 3 i-Bu TABLE 63 (R 2 is OCH 2 CF 3 , R 3 is C0 2 Me) TABLE 64 (R 2 is Cl, R 3 is 4-F-Ph) TABLE 65 (R 2 is F, R 3 is 4-F-Ph) TABLE 66 (R 2 is OCH 2 CF 3 , R 3 is 4-F-Ph) 1249 294 TABLE 67 (R 3 is 4-F-Ph) E 1 X z- CF 3 CH 2 SiMe 3 CF 3 CH 2 CF 3 CF 3 CH 2 CCH CF 3 CH 2 C0 Me CF 3 CH 2 CN CF 3 i-Pr CF 3 Ph C 3 4-Cl-Ph CF 3 4-OMe-Ph CF 3 4-F-Ph CF 3 t-Bu CF 3 CH 2 SOCH 3 CF 3 CH 2 S0 2 CH 3 CF 3 SN(i-Pr)C0 2 Et ~~3 SN(Me)C0 2 Et CF 3 SN(n-Bu) 2 CF S S (Me)C0 2 (n-Bu) CF 3 SN(i-Pr)C0 2 (n-Bu) CF 3 SN(i-Pr)C0 2 (n-Pr) CF 3 n-Bu C 3 i-Bu u) r) TABLE 6g rH rH rH rH rH rH rH rt fa fa fa fa fa O O υ o υ o o o o fa fa fa fa fa fa I I I I I I I I I I I I I I I I I 04 t^ r- r- l~ I- t- r- ι » r- co co co co co co co fo co co co co co co fo co fo fo co co co co co co co fo fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa o o3 & δ 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 o to CO co co co co co co co to co fa fa fa fa fa fa fa fa fa fa υ O O O O o CM o o υ υ CM CM CM CM CM CM CM CM CM as co CO CO CO CO CO CO O CO CO ES SC EC SC EC SB as as 8 fa fa fa fa fa fa af fa O O O O O O O O O O I I I I I I & 8 8 8 υ rH o υ I 8 I 8 I 8 I I 8 rH rH I 1 I I 03 t- r- l~- o o co fO CO CO fO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO ON rH Λ U U U fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa fa 3 ø3 ø) cQ ø) cQ o υ o o o υ o o υ o o o υ υ o υ o υ υ o υ υ ε. § 3 co co co co co co to fa fa fa fa fa fa fa rH 03 888 88 8 8 o O 03 co co to co to co to co co co co to co fa fa fa fa fa fa fa ON rH fa fa fa fa fa fa O O O O O O O rt rt 03 ϋ O O O O O O O O O O O O O O O O O O O O O O O O CM ON I 3 CΛ Xi 2 co o rH rH rH r-l rH <-i fa fa o O O υ O O O O O fa fa fa fa fa fa fa fa fa o o I I I I I I I I I I I I I I I I I I -A r- t- r» C- l > - I- I- t- ON τH M rH rH <-i -H rH rH rH rH rH rH rH rH rH rH >-i rH rH rH rH 03 ft O O O o o o o o o o o o o o o o o υ υ CM ON % E^ E J Cl 7-CF 3 n-Pr Cl 7-CF 3 i-Pr Cl 7-CF 3 C0 2 Me Cl 7-CF 3 C0 2 Et Br 7-C1 C0 2 Et Br 7-C1 Ph Br 7-C1 4-Cl-Ph Br 7-C1 4-F-Ph Br 7-F Me Br 7-F Et Br 7-F n-Pr Br 7-F i-Pr Br 7-F C0 2 Me Br 7-F C0 2 Et Br 7-F Ph Br 7-F 4-Cl-Ph Br 7-F 4-F-Ph Br 7-CF 3 Me Br 7-CF 3 Et Br 7-CF 3 n-Pr Br 7-CF 3 i-Pr Br 7-CF 3 C0 2 Me Br 7-CF 3 C0 2 Et Br 7-CF 3 Ph Br 7-CF 3 4-Cl-Ph Br 7-CF 3 4-F-Ph Br 7-OCH 2 CF 3 Me Br 7-OCH 2 CF 3 Et TABLE 71 B z- CF 3 7-C1 Me CF 3 7-C1 Et CF 3 7-C1 n-Pr CF 3 7-C1 C0 2 Me CF 3 7-C1 4-F-Ph OCF 3 7-C1 Me OCF 3 7-C1 Et OCF 3 7-C1 n-Pr OCF 3 7-C1 C0 2 Me OCF 3 7-C1 4-F-Ph CF 3 7-F Me CF 3 7-F Et CF 3 7-F n-Pr CF 3 7-F C0 2 Me CF 3 7-F 4-F-Ph OCF 3 7-F Me OCF 3 7-F Et OCF 3 7-F n-Pr OCF 3 7-F C0 2 Me OCF 3 7-F 4-F-Ph to co co co co co co co co co to fa to fa co co fa fa fa fa fa co to co co fa fa fa fa fa x* rt ^ fa fa fa o o o o fa fa fa fa fa o o g o o Cxi 03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 I ON o Formulation and Use The compounds of this invention will generally be used in formulation with an agriculturally suitable carrier comprising a liquid or solid diluent or an organic solvent. Useful formulations of the compounds of Formulas I and II can be prepared in conventional ways. They include dusts, granules, baits, pellets, solutions, suspensions, emulsions, wettable powders, emulsifiable concentrates, dry flowables and the like. Many of these can be applied directly. Sprayable formulations can be extended in suitable media and used at spray volumes of from about one to several hundred liters per hectare. High strength compositions are primarily used as intermediates for further formulatio . The formulations, broadly, contain from less than about 1% to 99% by weight of active ingredient(s) and at least one of a) about 0.1% to 20% surfactant<s) and b) about 5% to 99% solid or liquid diluent(s) . More specifically, they will contain effective amounts of these ingredients in the following approximate proportions: Percent By Weight 1-10 0-15 0-5 0-15 0-2 Lower or higher levels of active ingredient can, of course, be present depending on the intended use and the physical properties of the compound. Higher ratios of surfactant to active ingredient are sometimes desirable, and are achieved by incorporation into the formulation or by tank mixing. Typical solid diluents are described in Watkins, et al., "Handbook of Insecticide Dust Diluents and Carriers", 2nd Ed., Dorland Books, Caldwell, New Jersey. The more absorptive diluents are preferred for wettable powders and the denser ones for dusts. Typical liquid diluents and solvents are described in Marsden, "Solvents Guide," 2nd Ed., Interscience, New York, 1950. Solubility under 0.1% is preferred for suspension concentrates; solution concentrates are preferably stable against phase separation at 0°C. "McCutcheon's Detergents and Emulsifiers Annual", Allured Publ. Corp., Ridgewood, New Jersey, as well as Sisely and Wood, "Encyclopedia of Surface Active Agents", Chemical Publ. Co., Inc., New York, 1964, list surfactants and recommended uses. All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth, etc. Preferably, ingredients should be approved by the U.S. Environmental Protection Agency for the use intended. The methods of making such compositions are well known. Solutions are prepared by simply mixing the ingredients. Fine solid compositions are made by blending and, usually, grinding as in a hammer or fluid energy mill. Suspensions are prepared by wet milling (see, for example, U.S. 3,060,084). Granules and pellets can be made by spraying the active material upon preformed granular carriers or by agglomeration techniques. See J. E. Browning, "Agglomeration", Chemical Engineering. December 4, 1967, pages 147 and following, and "Perry's Chemical Engineer's Handbook", 4th Ed., McGraw-Hill, New York, 1963, pages 8 to 59 and following. Exa le Emulsifiable Concentrate 7-chloro-4a-(4-chlorophenyl)-4a,5-dihydro- N-[4-(trifluoromethyl)phenyl]indeno- [1,2-e] [1,3,4]-oxadiazine-2(3H)-carboxamide 20% blend of oil soluble sulfonates and polyoxyethylene ethers 10% isophorone 70% The ingredients are combined and stirred with gentle warming to speed solution. A fine screen filter is included in packaging operation to insure the absence of any extraneous undissolved material in the product. Example S Wettable Powder 7-chloro-4a-(4-chlorophenyl)-4a,5-dihydro- N-[4-(trifluoromethyl)phenyl]indeno- [1,2-e] [1,3,4]-oxadiazine-2(3H)-carboxamide 30% sodium alkylnaphthalenesulfonate 2% sodium ligninsulfonate 2% synthetic amorphous silica 3% kaolinite 63% The active ingredient is mixed with the inert materials in a blender. After grinding in a hammer- mill, the material is re-blended and sifted through a 50 mesh screen. Example C Dust Wettable powder of Example B 10% pyrophyllite (powder) 90% The wettable powder and the pyrophyllite diluent are thoroughly blended and then packaged. The product is suitable for use as a dust. Example D Granule 7-chloro-4a-(4-chlorophenyl)-4a,5-dihydro- N-[4-(trifluoromethyl)phenyl]indeno- [1,2-e] [1,3,4]-oxadiazine-2(3H)- carboxamide 10% attapulgite granules (low volative matter, 0.71/0.30 mm; U.S.S. No. 25-50 sieves) 90% The active ingredient is dissolved in a volatile solvent such as acetone and sprayed upon dedusted and pre-warmed attapulgite granules in a double cone blender. The acetone is then driven off by heating. The granules are then allowed to cool and are packaged. Example E Granule Wettable powder of Example B 15% gypsum 69% potassium sulfate 16% The ingredients are blended in a rotating mixer and water sprayed on to accomplish granulation. When most of the material has reached the desired range of 0.1 to 0.42 mm (U.S.S. No. 18 to 40 sieves), the granules are removed, dried, and screened. Oversize material is crushed to produce additional material in the desired range. These granules contain 4.5% active ingredient. Example F Solution 7-chloro-4a-(4-chlorophenyl)-4a,5-dihydro- N-[4-(trifluoromethyl)phenyl]indeno- [1,2-e] [1,3,4]-oxadiazine-2(3H)- carboxamide 25% N-methyl-pyrrolidone 75% The ingredients are combined and stirred to produce a solution suitable for direct, low volume application. Example G Aqueous Suspension 7-chloro-4a-(4-chlorophenyl)-4a,5-dihydro- N-[4-(trifluoromethyl)phenyl]indeno- [1,2-e] [l,3,4]-oxadiazine-2(3H)- carboxamide 40% polyacrylic acid thickener 0.3% dodecyclophenol polyethylene glycol ether 0.5% disodium phosphate 1.0% monosodium phosphate 0.5% polyvinyl alcohol 1.0% water 56.7% The ingredients are blended and ground together in a sand mill to produce particles substantially all under 5 microns in size. Example H Oil Suspension 7-chloro-4a-(4-chlorophenyl)-4a,5-dihydro- N-[4-(trifluoromethyl)phenyl]indeno- [1,2-e] [1,3,4]-oxadiazine-2 (3H)-carboxamide 35.0% blend of polyalcohol carboxylic esters and oil soluble petroleum sulfonates 6.0% xylene range solvent 59.0% The ingredients are combined and ground together in a sand mill to produce particles substantially all below 5 microns. The product can be used directly, extended with oils, or emulsified in water. Example I Bait Granules 7-chloro-4a-(4-chlorophenyl)-4a,5-dihydro- N-[4-(trifluoromethyl)phenyl]indeno- [1,2-e] [1,3,4]-oxadiazine-2(3H)-carboxamide 3.0% blend of polyethoxylated nonyl-phenols and sodium dodecyl-benzene sulfonates 9.0% ground up corn cobs 88.0% The active ingredient and surfactant blend are dissolved in a suitable solvent such as acetone and sprayed onto the ground corn cobs. The granules are then dried and packaged. Compounds of Formulas I and II can also be mixed with one or more other insecticides, fungicides, nematocides, bactericides, acaricides, or other biologically active compounds to form a multi-component pesticide giving an even broader spectrum of effective agricultural protection. Examples of other agricultural protectants with which compounds of this invention can be formulated are: Insecticides: 3-hydroxy-N-methylcrotonamide(dimethylphosphate)ester (monocrotophos) methylcarbamic acid, ester with 2,3-dihydro-2,2- dimethyl-7-benzofuranol (carbofuran) O-[2,4,5-trichloro-α-(chloromethyl)benzyl]phosphoric acid, O',O'-dimethyl ester (tetrachlorvinphos) 2-mercaptosuccinic acid, diethyl ester, S-ester with thionophosphoric acid, dimethyl ester (malathion) phosphorothioic acid, 0,0-dimethyl, O-p-nitrophenyl ester (methyl parathion) methylcarbamic acid, ester with a-naphthol (carbaryl) methyl O-(methylcarbamoy1)thiolacetohydroxamate (methomyl) N'-(4-chloro-ώ-tolyl)-N,N-dimethylformamidine (chlordimeform) O,O-diethyl-O-(2-isopropyl-4-methyl-6-pyrimidylphos- phorothioate (diazinon) octachlorocamphene (toxaphene) 0-ethyl-O-p-nitrophenyl phenylphosphonothioate (EPN) (S)-α-cyano-m-phenoxybenzyl(1R,3R)-3-(2,2-dibromovinyl)- 2,2-dimethylcyclopropanecarboxylate (deltamethrin) Methyl- ',N'-dimethyl-N-[(methylcarbamoyl)oxy]-1-thioox amimidate (oxamyl) cyano(3-phenoxyphenyl)-methyl-4-chloro-a-(1-methyl- ethyl)benzeneacetate (fenvalerate) (3-phenoxyphenyl)methyl(±)-cis,trans-3-(2,2- dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate (permethrin) a-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2- dimeth lcyclopropane carboxylate (cypermethrin) O-ethyl-S-(p-chlorophenyl)ethylphosphonodithioate (profenofos) phosphorothiolothionic acid. 0-ethyl-O-[4-(methylthio)-phenyl]-S-n-propyl ester (sulprofos) . Additional insecticides are listed hereafter by their common names: triflumuron, diflubenzuron, methoprene, buprofezin, thiodicarb, acephate, azinphosmethyl, chlorpyrifos, dimethoate, fonophos, isofenphos, methidathion, methamidiphos, monocrotphos, phosmet, phosphamidon, phosalone, pirimicarb, phorate, terbufos, trichlorfon, methoxychlor, bifenthrin, biphenate, cyfluthrin, fenpropathrin, fluvalinate, flucythrinate, tralomethrin, metaldehyde and rotenone. Fungicides: methyl 2-benzimidazolecarbamate (carbendazim) tetramethylthiuram disulfide (thiura ) n-dodecylguanidine acetate (dodine) manganese ethylenebisdithiocarbamate (maneb) 1,4-dichloro-2,5-dimethoxybenzene (chloroneb) methyl 1-(butylcarbamoyl)-2-benzimidazolecarbamate (benomyl) 1-[2-(2,4-dichlorophenyl)-4-propyl-l,3-dioxolan-2- ylmethyl]-1H-1,2, -triazole (propiconazole) 2-cyano-N-ethylcarbamoyl-2-methoxyiminoacetamide (cymoxanil) l-(4-chlorophenoxy)-3,3-dimethyl-l-(lH-l,2,4-triazol-l- yl)-2-butanone (triadimefon) N-(trichloromethylthio)tetrahydrophthalimide (captan) N-(trichloromethylthio)phthalimide (folpet) 1-[ [ [bis (4-fluorophenyl) ] [methyl]sil 1] ethyl]-1H-1,2,4- triazole Nematicides: S-methyl 1-(dimethylcarbamoyl)-N-(methylcarbamoyloxy)- thioformimidate S-methyl 1- carbamoyl -N- (methylcarbamoyloxy) - thioformimidate N-isopropylphosphoramidic acid O-ethyl 0 ' - [4- (methyl- thio) -m-tolyl] diester (fenamiphos) Bactericides : tribasic copper sulfate streptomycin sulfate Acaricides : senecioic acid, ester with 2-.ge-c.-butyl-4, 6-dinitro- phenol (binapacryl ) 6-methyl-l, 3-cithiolo [4, 5-β] quinoxalin-2-one (oxythioquinox) ethyl 4, 4 ' -dichlorobenzilate (chlorobenzilate) 1, 1-bis (p-chlorophenyl) -2, 2, 2-trichloroethanol (dicofol) bis (pentachloro-2, 4-cyclopentadien-l-yl) (dienochlor) tricyclohexyltin hydroxide (cyhexatin) trans-5- (4-chlorophenyl) -N-cyclohexyl-4-methyl-2-oxo- thiazolidine-3-carboxamide (hexythiazox) amitraz propargite fenbutatin-oxide Biological Bacillus thuringiensis Avermectin B. Utility Some of the compounds of this invention are characterized by favorable metabolic and/or soil residual patterns and exhibit activity against a wide spectrum of foliar and soil inhabiting arthropods which are pests of growing and stored agronomic crops, forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, and public and animal health. Those skilled in the art will recognize that not all compounds are equally effective against all pests. For example, some of the compounds where Y is alkyl have enhanced field efficacy. The compounds of this invention display activity against economically important agronomic, forestry, greenhouse, ornamental food and fiber product, stored product, domestic structure, and nursery pests, such as: larvae of the order Lepidoptera including fall and beet armyworm and other Spodoptera spp., tobacco budworm, corn earworm and other Heliothis spp., European corn borer, navel orangeworm, stalk/stem borers and other pyralids, cabbage and soybean loopers and other loopers, codling moth, grape berry moth and other tortricids, black cutworm, spotted cutworm, other cutworms and other noctuids, diamondback moth, green cloverworm, velvetbean caterpillar, green cloverworm, pink bollworm, gypsy moth, and spruce budworm; foliar feeding larvae and adults of the order Coleoptera including Colorado potato beetle, Mexican bean beetle, flea beetle, Japanese beetles, and other leaf beetles, boll weevil, rice water weevil, granary weevil, rice weevil and other weevil pests, and soil inhabiting insects such as Western corn rootworm and other Diabrotica spp., Japanese beetle, European chafer and other coleopteran grubs, and wireworms; adults and larvae of the orders Hemiptera and Homoptera including tarnished plant bug and other plant bugs ( iridae) , aster leafhopper and other leafhoppers (c-if-adellidae , rice planthopper, brown planthopper, and other planthoppers (fulgoroidea) , psyiids, whiteflies (aleurodiflae) r aphids (aphidae) , scales fπoccidae and diaspididae) , lace bugs (tingidae) , stink bugs (pentatomidae) , cinch bugs and other seed bugs (lygaeidae) , cicadas (cicadidaeϊ , spittlebugs (cercopids) , squash bugs (coreidae), red bugs and cotton stainers (pyrrhocoridae); adults and larvae of the order acari (mites) including European red mite, two spotted spider mite, rust mites, McDaniel mite, and foliar feeding mites; adults and immatures of the order Orthoptera including grasshoppers; adults and immatures of the order Diptera including leafminers, midges, fruit flies (tephritidaeϊ , and soil maggots; adults and immatures of the order Thysanoptera including onion thrips and other foliar feeding thrips. The compounds are also active against economically important livestock, household, public and animal health pests such as: insect pests of the order Hymenop era including carpenter ants, bees, hornets, and wasps; insect pests of the order Diptera including house flies, stable flies, face flies, horn flies, blow flies, and other muscoid fly pests, horse flies, deer flies and other Brachycera, mosquitoes, black flies, biting midges, sand flies, sciarids, and other Nematocera: insect pests of the order Orthoptera including cockroaches and crickets; insect pests of the order Isoptera including the Eastern subterranean termite and other termites; insect pests of the order Mallophaga and Anoplura including the head louse, body louse, chicken head louse and other sucking and chewing parasitic lice that attack man and animals; insect pests of the order Siphonoptera including the cat flea, dog flea and other fleas. The specific species for which control is exemplified are: fall armyworm, Spodoptera fruigiperda; tobacco budworm, Heliothis vir scens; boll weevil, Anthonomus grandis: aster leafhopper, Macrosteles fascifrons; black bean aphid, (&plιi≤. Ea-ba≤.) ; southern corn rootworm, Diabrotica undecimpunctat ♦ The pest control protection afforded by the compounds of the present invention is not limited, however, to these species. The compounds of this invention may also be utilized as rodenticides. Application Arthropod pests are controlled and protection of agronomic crops, animal and human health is achieved by applying one or more of the Formula I or II compounds of this invention, in an effective amount, to the environment of the pests including the agronomic and/or nonagronomic locus of infestation, to the area to be protected, or directly on the pests to be controlled. Because of the diversity of habitat and behavior of these arthropod pest species, many different methods of application are employed. A preferred method of application is by spraying with equipment that distributes the compound in the environment of the pests, on the foliage, animal, person, or premise, in the soil or animal, to the plant part that is infested or needs to be protected. Alternatively, granular formulations of these toxicant compounds can be applied to or incorporated into the soil. Other methods of application can also be employed including direct and residual sprays, aerial sprays, baits, eartags, boluses, foggers, aerosols, and many others. The compounds can be incorporated into baits that are consumed by the arthropods or in devices such as traps and the like which entice them to ingest or otherwise contact the compounds. The compounds of this invention can be applied in their pure state, but most often application will be of a formulation comprising one or more compounds with suitable carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use. A preferred method of application involves spraying a water dispersion or refined oil solution of the compounds. Combinations with spray oils, spray oil concentrations, and synergists such as piperonyl butoxide often enhance the efficacy of the compounds of Formulae I and II. The rate of application of the Formula I and II compounds required for effective control will depend on such factors as the species of arthropod to be controlled, the pest's life cycle, life stage, its size, location, time of year, host crop or animal, feeding behavior, mating behavior, ambient moisture, temperature, etc. In general, application rates of 0.01 to 2 kg of active ingredient per hectare are sufficient to provide large-scale effective control of pests in agronomic ecosystems under normal circumstances, but as little as 0.001 kg/hectare or as much as 8 kg hectare may be required. For nonagronomic applications, effective use rates will range from about 1.0 to 50 mg/square meter but as little as about 0.1 mg/square meter or as much as 150 mg/square meter may be required. The following Tests demonstrate the control efficacy of compounds of Formulae I and II on specific pests; see Index Tables A, B, C, D, E and F for compound descriptions. 3 oo CM S * rH o CM o o ON i rH I m r- VO VO ON O 00 ON CM lO H rH rH rH CM •K o ON Λ l I I 3 co vo co oo σv co σ. oo e oo H ■rt a frt CM in vo m io oo o o oo •H r- CM H rH r-I H rH f-I CM m O O O 0 rH Cmpd E E^ ° 51 CF 3 F 52 OCF 3 F 53 CF3 F 54 OCF3 F 55 CF3 F 63 OCF3 Cl 64 CF3 CF3 81 Cl F INDEX TABLE R Cmpd fi- E p (°C) 22 OCF3 Cl C0 2 Me H Me 130-131 23 OCF3 Cl Cθ2Me Me H 162-166 24 OCF3 Cl C02Me H C0 2 Me oil* 25 OCF3 Cl Cθ2Me H COMe oil* 26 Br F 4-F-Ph H Me 161-163 27 Br F 4-F-Ph H C0 2 Me 187-189 28 Br F 4-F-Ph H COMe 91-93 29 Br F 4-F-Ph Me H 198 (dec) 249 324 £mpd R- E^ E~ E mp f °C) 30 Br F 4-F-Ph Et H 219-221 31 OCF 3 Cl C0 2 Me Et H 151-152 32 CF 3 F C0 2 Me Me H 168-171 33 OCF3 F C0 2 Me Me H 155-157 34 OCF3 F 4-F-Ph Et H 150-152 35 OCF3 F 4-F-Ph Me H 149-151 36 Br Cl C0 2 Me H Me 114-116 37 CF3 Cl C0 2 Me H Me 133-135 38 CF3 F C0 2 Me Et H 168-170 39 CF3 Cl C0 2 Me H COMe gum* 40 Br Cl C0 2 Me H C0 Me oil* 41 OCF3 F C0 2 Me H Me 143-145 42 CF3 F C0 2 Me H Me 198-200 43 OCF3 Cl C0 2 Et H Et oil* 44 OCF3 Cl C0 2 Me H Et 120.5-122 45 CF 3 Cl C0 2 Et H Et oil* 46 CF3 Cl C0 2 Me H Et oil* 47 OCF3 Cl C0 2 Me H C0 2 Et oil* 48 Br F 4-F-Ph H C0 2 Et oil* 49 Br F 4-F-Ph H Et 177-178 50 Br F 4-F-Ph H COMe oil* 65 OCF3 Cl C0 2 Et H Me oil* 66 OCF3 F 4-F-Ph H C0 2 Et 170-173 67 OCF3 F 4-F-Ph H Et 164-166 68 Br F 4-F-Ph H CH SMe 158-160 INDEX TABLE C £mpd E B, 4 B- mp(°C) 56 OCF 3 F 4-F-Ph 180-184 57 OCF3 Cl 4-F-Ph 129-133 69 OCF3 F Me 125-127 INDEX TABLE D £mpd 3 58 OCF 3 59 CF 3 60 CF3 61 CF3 62 OCF3 70 OCF3 71 CF 3 72 Br 73 Cl 74 OCF3 75 CF 3 76 Br 77 Cl 78 OCF3 79 CF 3 80 Br INDEX TABLE E £mpd -B 1 E^ £ • = mp(°C) 82 OCF 3 Cl C0 2 CH 3 135-140(d) INDEX TABLE F Cmpd E 1 -B" E-* mp(°C) 83 H H Ph H oil* * See Table G for additional data on selected compounds of Tables A-F. TABLE G CMPD ^-H NMR Data (200 MHz, CDCI 3 solution) 9 δ 1.51 (s, 3H), 3.14 (abq, 2H) , 5.20 (d, IH) , 5.73 (d, IH), 7.18 (d, 2H), 7.35 (d, 2H) , 7.51-7.61 (m, 3H) , 8.40 (s, IH) . 11 δ 0.92 (t, 3H), 1.22-1.62 (m, 3H) , 1.8-2.0 (m, IH), 3.13 (abq, 2H) , 5.19 (d, IH) , 5.56 (d, IH), 7.18 (d, 2H), 7.33 (d, 2H) , 7.51-7.62 (m, 3H), 8.39 (s, IH) . 12 δ 0.92 (t, 3H), 1.3-1.6 ( , 3H) , 1.8-2.0 (m, IH), 3.12 (abq, 2H) , 5.19 (d, IH) , 5.55 (d, IH) , 7.31 (apparent d, 2H) , 7.43 (apparent s, 4H), 7.57 (d, IH), 8.36 (s, IH) . 13 δ 0.92 (t, 3H), 1.2-1.6 ( , 3H) , 1.8-2.0 (m, IH), 3.15 (abq, 2H) , 5.18 (d, IH) , 5.55 (d, IH), 7.24-7.38 (m, 4H) , 7.50 (d, 2H) , 7.57 (d, IH) , 8.36 (s, IH) . 4 δ 3-.43 (abq, 2H) , 3.74 (s, 3H) , 5.07 (d, IH) , 5.97 (d, IH), 7.21 (d, 2H) , 7.5-7.7 (m, 4H) , 7.81 (d, IH), 8.38 (br s, IH) . 4 δ 3.25 (d, IH) , 3.51 (d, IH) , 3.72 (s, 3H) , 3.73 (s, 3H), 5.22 (d, IH) , 5.72 (d, IH) , 7.20-7.42 (m, 6H) , 7.53 (d, IH) . 5 δ 2.23 (s, 3H), 3.21 (d, IH), 3.47 (d, IH) , 3.66 (s, 3H), 5.22 (d, IH) , 5.65 (d, IH) , 7.18-7.45 (m, 7H) . CMPD 1 H NMR Data (200 MHz, CDCI 3 solution) 39 δ 2.27 (s, 3H), 3.20 (d, IH) , 3.44 (d, IH) , 3.65 (s, 3H), 5.24 (d, IH) , 5.66 (d, IH) , 7.23-7.45 (m, 5H) , 7.64 (d, 2H) . 40 δ 3.39 (abq, 2H) , 3.71 (s, 3H) , 3.72 (s, 3H) , 5.21 (d, IH), 5.69 (d, IH) , 7.18-7.38 (m, 4H), 7.43-7.57 (m, 3H) . 43 δ 1.05-1.20 (m, 5H) , 3.23 (abq, 2H) , 3.65-3.95 (m, 2H), 4.02-4.2 (m, 2H) , 5.17 (d, IH) , 5.44 (d, IH), 6.93 (d, IH) , 7.14 (apparent s, 5H) , 7.19 (apparent s, IH) . 45 δ 1.08-1.30 (m, 5H) , 3.10 (d, IH) , 3.37 (d, IH), 3.70-3.95 (m, 2H) , 4.0-4.2 (m, 2H) , 5.17 (d, IH) , 5.47 (d, IH) , 6.72 (d, IH) , 7.19 (distorted t, 4H) , 7.54 (d, 2H) . 46 δ 1.22 (t, 3H), 3.09 (d, IH) , 3.38 (d, IH) , 3.67 (s, 3H), 3.72-3.98 (m, 2H) , 5.20 (d, IH), 5.42 (d, IH), 6.75 (d, IH) , 7.19 (distorted t, 4H) , 7.54 (d, 2H) . 47 δ 1.16 (t, 3H), 3.38 (abq, 2H) , 3.72 (s, 3H) , 4.05-4.25 (m, 2H) , 5.20 (d, IH) , 5.76 (d, IH) , 7.10-7.26 ( , 2H) , 7.36 (distorted t, 4H), 7.54 (d, IH) . 48 δ 1.22 (t, 3H) , 3.47 (abq, 2H) , 4.23 (q, 2H) , 4.60 (d, IH), 5.61 (d, IH) , 6.92-7.10 (m, 4H) , 7.12-7.25 (m, 4H) , 7.49 (distorted d, 2H), 7.63 (dd, IH) . CMPD ^-H NMR Data (200 MHz, CDCI 3 solution) 50 δ 2.19 (s, 3H), 3.34 (abq, 2H) , 3.66 (s, 3H) , 5.22 (d, IH), 5.64 (d, IH) , 7.18-7.37 (m, 4H), 7.42-7.51 (m, 3H) . 65 δ 1.15 (t, 3H), 3.13 (d, IH), 3.35 (d, IH) , 3.38 (s, 3H) , 4.0-4.2 (m, 2H) , 5.19 (d, IH) , 5.44 (d, IH), 6.83 (d, IH) , 7.15 (apparent s, 5H), 7.19 (br s, IH) . 81 δ 1.51 (s, 3H), 3.17 (abq, 2H) , 5.20 (d, IH) , 5.72 (d, IH), 7.02-7.17 (m, 2H) , 7.43 (s, 4H), 7.62 (dd, IH), 8.38 (br s, IH) . 83 δ 6.50 (s, IH), 7.4-7.8 (m, 14H) , 10.6 (bs, IH) . TEST A Fall Army orm Test units, each consisting of an 8-ounce (230 L) plastic cup containing a layer of wheat germ diet, approximately 0.5 cm thick, were prepared. Ten third- instar larvae of fall armyworm (Spodoptera frugiperda) were placed into each cup. Solutions of each of the test compounds (acetone/distilled water 75/25 solvent) were sprayed into the cups, a single solution per set of three cups. Spraying was accomplished by passing the cups, on a conveyer belt, directly beneath a flat fan hydraulic nozzle which discharged the spray at a rate of 0.5 pounds of active ingredient per acre (about 0.55 kg/ha) at 30 p.s.i. (207 kPa) . The cups were then covered and held at 27°C and 50% relative humidity for 72 hours, after which time readings were taken. Of the compounds tested, the following resulted in greater than or equal to 80% mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 15, 19, 20, 21, 22, 23, 25, 26, 27, 28, 29, 31, 34, 35, 36, 37, 39, 40, 43, 44, 45, 46, 47, 48, 49, 51, 52, 53, 54, 55, 56, 58, 61, 62, 63, 65, 70, 74, 78, 79, 80. TEST B Tobacco Budworm The test procedure of Test 1 was repeated for efficacy against third-instar larvae of the tobacco budworm (Heliothis virescens) except that mortality was assessed at 48 hours. Of the compounds tested, the following resulted in greater than or equal to 80% mortality: 2, 3, 4, 6, 7, 8, 9, 10, 11, 12, 15, 16, 17, 18, 19, 20, 21, 22, 23, 25, 26, 27, 28, 29, 32, 33, 34, 35, 37, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 51, 52, 53, 54, 55, 56, 61, 62, 63, 65, 70, 71, 74, 79. TEST C Southern Corn Root orm Test units, each consisting of an 8-ounce (230 mL) plastic cup containing 1 sprouted corn seed, were prepared. Sets of three test units were sprayed as described in Test A with individual solutions of the test compounds. After the spray on the cups had dried, five third-instar larvae of the southern corn rootworm ■Diabrotica undecimpunctata howardiϊ were placed into each cup. A moistened dental wick was inserted into each cup to prevent drying and the cups were then covered. The cups were then held at 27°C and 50% relative humidity for 48 hours, after which time mortality readings were taken. Of the compounds tested, the following resulted in greater than or equal to 80% mortality: 1, 2, 3, 6, 7, 8, 9, 10, 11, 12, 15, 16, 17, 18, 19, 20, 21, 22, 23, 25, 26, 27, 28, 32, 35, 36, 37, 39, 41, 42, 43, 44, 46, 47, 48, 49, 51, 52, 53, 54, 55, 56, 59, 61, 62, 63, 65, 70, 71, 74, 75, 76, 77, 78, 79, 80. TEST D Aster Leafhopper Test units were prepared from a series of 12-ounce (350 mL) cups, each containing oat (Avena satival seedlings in a 1-inch (2.54 cm) layer of sterilized soil. The test units were sprayed as described in Test A with individual solutions of the below-listed compounds. After the oats had dried from the spraying, between 10 and 15 adult aster leafhoppers (Mascrosteles fascifrons) were aspirated into each of the covered cups. The cups were held at 27°C and 50% relative humidity for 48 hours, after which time mortality readings were taken. Of the compounds tested, the following resulted in greater than or equal to 80% mortality: 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 15, 16, 17, 18, 19, 21, 22, 25, 26, 27, 28, 35, 36, 37, 39, 40, 41, 43, 44, 45, 46, 47, 48, 49, 51, 52, 53, 54, 55, 56, 63, 65, 70, 71, 74, 76, 77, 78, 79. E≤I -E Boll Weevil Five adult boll weevils (Anthonomus grandis grandis) were placed into each of a series of 9 ounce (260 L) cups. The test procedure employed was then otherwise the same as in Test A with three cups per treatment. Mortality readings were taken 48 hours after treatment. Of the compounds tested, the following resulted in greater than or equal to 80% mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 15, 16, 18, 19, 20, 21, 22, 23, 25, 26, 27, 28, 32, 33, 35, 37, 39, 41, 42, 43, 44, 45, 46, 47, 48, 49, 51, 52, 53, 54, 55, 56, 61, 62, 63, 65, 70, 71, 74, 75, 76, 77, 78, 79, 80.

Claims: £LAIM£ What is claimed is: A compound of Formula I or II: X II I Q—C—N—G Q—C=N- II wherein : Q is selected from the group Q-l Q-2 Q-3 Q-4 Q-5 Q-6 A is H; E is selected from the group H and C1-C3 alkyl; or A and E can be taken together to form -CH 2 -, -CH 2 CH 2 -, -0-, -S-, -S(O)-, -S(0) 2 -, -NR 7 -, -0CH 2 -, -SCH 2 -, -N(R 7 )CH 2 -, substituted -CH 2 - f and substituted -CH 2 CH 2 - the substituents independently selected from 1-2 halogen and 1-2 methyl; G is selected from the group G-l G-2 G-3 G-4 G-5 G-6 G-l G-8 G-9 X is selected from the group 0, S and N-X 2 ; X-- is selected from the group Cl, Br, OR , SR 8 and NR 8 R 9 ; X 2 is selected from the group R 8 , OH, OR 8 , CN, S0 R 8 , S0 2 Ph, 0C(0)NR 9 R 10 , 0C(0)0R 8 , NR 9 R 10 and phenyl optionally substituted with R 1 *; Y is selected from the group H; C^-Cg alkyl; benzyl; c 2 -c 6 alkoxyalkyl; C 2 -Cg alkenyl; C -Cg alkynyl; Cχ-C alkyl optionally substituted by halogen, c l~ c 3 alkoxy, C1-C3 haloalkoxy, CN, N0 , S(0) r R 32 , COR 32 , C0 2 R 32 , phenyl optionally substituted by halogen, CN, Cι~C 2 haloalkyl and c l -c 2 haloalkoxy; C3—Cg cycloalkyl; C3~Cg cyclohaloalkyl; C3~C cycloalkylalkyl; CHO; C 2 -Cg alkylcarbonyl; C 2 -Cg alkoxycarbonyl; C 2 -Cg haloalkylcarbonyl; COR 36 ; C0 R 36 ; ^-Cg alkylthio; C^-Cg haloalkylthio; phenylthio; R 12 OC(0)N(R 13 )S- and R 14 (R 15 )NS-; A 1 is H; ^ and Y can be taken together to form -(CH 2 ) --; Z is C or N; Z 1 is O, S or NR 31 ; R^- and R 2 are independently selected from the group H, Cι~C alkyl, Cj-Cg haloalkyl, C 2 -Cg alkenyl, C -Cg haloalkenyl, C 2 -Cg alkynyl, C3~Cg haloalkynyl, C 2 -Cg alkoxyalkyl, C 2 -Cg alkylthioalkyl, C^-Cg nitroalkyl, C -Cg cyanoalkyl, C3-C8 alkoxycarbonylalkyl, C3~Cg cycloalkyl, C3~Cg halocycloalkyl, halogen, CN, N 3 , SCN, N0 2 , OR 17 , SR 17 , S(0)R 17 , S(0) 2 R 17 , OC(0)R 17 , OS(0) 2 R 17 , C0 2 R 17 , C(0)R 17 , C(0)NR 17 R 18 , S0 2 NR 17 R 18 , NR 17 R 18 , NR 18 C(0)R 17 , 0C(0)NHR 17 , NR 18 C(0)NHR 17 , NR 18 S0 2 R 17 , phenyl optionally substituted with 1 to 3 substituents independently selected from W, and benzyl optionally substituted with 1 to 3 substituents independently selected from W; or when m or n is 2, (R 1 ) can be taken together, or (R 2 ) 2 can be taken together as -OCH 2 0-, -OCF 2 0-, -OCH 2 CH 0-, -CH 2 C(CH 3 ) 2 0-, -CF 2 CF 2 0 or -OCF 2 CF 2 0- to form a cyclic bridge; provided that when R^ or R 2 is S(0)R 17 , S(0) 2 R 17 , 0C(0)R 17 or 0S(0) R 17 then R 17 is other than H; R3 is selected from the group H, J, N3, N0 , halogen, N(R 22 )R 23 , C(R 34 )=N-0-R 35 , ^-Cg alkyl, C^Cg haloalkyl, C 2 -Cg alkenyl, C 2 -Cg haloalkenyl, C -Cg alkynyl, C 2 -Cg alkoxylalkyl, C3-C8 alkoxycarbonylalkyl, C0 R 17 , OR 19 , C(0)R 17 , C(0)NR 17 R 18 , C(S)NR 17 R 18 , C(S)R 17 , C(S)SR 17 , CN, Si(R 28 ) (R 29 )R 27 , SR 27 , S(0)R 27 , S0 2 R 27 , -P (0) (OR 27 ) 2 , phenyl, phenyl substituted with (Rl6) p , benzyl and benzyl substituted with 1 to 3 substituents independently selected from W; or R 3 is C 2 -Cg epoxyalkyl optionally substituted with a group selected from C1-C3 alkyl, CN, C(0)R 24 , C0 2 R 24 and phenyl optionally substituted with W; or R 3 is C^-C alkyl substituted with a group selected from C(0)N(R 2 5)R 26 , C(0)R 25 , SR 27 , S(0)R 27 , S0 2 R 27 , SCN, CN, Ci-C haloalkoxy, Si(R 28 ) (R 29 )R 30 , N(R 22 )R 23 , N0 2 , OC(0)R 25 , - P(O) (OR 27 ) and J; J is selected from the group saturated, partially unsaturated or aromatic 5- or 6-membered heterocyclic ring, bonded through carbon or nitrogen, containing 1-4 heteroatoms independently selected from the group consisting of 0-2 oxygen, 0-2 sulfur and 0-4 nitrogen, this substituent optionally containing one carbonyl and optionally substituted with one or more members selected from W; R 4 and 5 are independently selected from the group H, C1-C4 alkyl, COR 20 and C 2 -C4 alkoxycarbonyl; or R 4 and R5 can be taken together to form =0 or =S; R 6 is selected from the group H, C1-C4 alkyl, C1-C4 haloalkyl, C 2 -C4 alkylcarbonyl, C 2 -C haloalkoxycarbonyl, C 2 -C4 alkoxycarbonyl C 2 -C4 haloalkoxycarbonyl, COR 36 , C0 2 R 36 , C 2 -Cs alkylaminocarbonyl, C3~Cg cycloalkyl, C3~Cg halocycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 haloalkylcycloalkyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl and S0 2 Ph optionally substituted with Cl, Br or CH3; R 7 is selected from the group H, C1-C4 alkyl, C1-C4 haloalkyl, C -C4 alkenyl, C 2 -C4 haloalkenyl, SR 17 , S(0)R 17 , S(0) 2 R 17 , C(0)R 17 , C0 2 R 17 , C(0)NR 17 R 21 , C(S)NR 17 R 21 , C(S)R 17 , C(S)OR 17 , -P(O) (OR 17 ) 2 , -P(S) (OR 17 ) 2 , P(0) (R 17 )OR 17 , P(0) (R 17 )SR 21 , and optionally substituted phenyl and benzyl wherein the substituent(s) are selected from F, Cl, Br, CH3, CF3 or OCF3; provided that when R 7 is other than C(0)Rl 7 , C(0)NR 17 R 21 or C(S)NR 17 R 21 then R 17 is other than H; R 8 is selected from the group C1-C3 alkyl, C -C4 alkenyl, C -C4 alkynyl, C1-C3 haloalkyl, C -C4 haloalkenyl, C3~Cg cycloalkyl; C1-C3 alkyl substituted with OCH3, OCH 2 CH 3 , N0 , CN, C0 2 CH3, C0 2 CH 2 CH3, SCH3 or SCH 2 CH3 and benzyl optionally substituted with R^; R 9 is selected from the group H, C1-C4 alkyl C1-C haloalkyl, C 2 -C alkoxycarbonyl, and optionally substituted phenyl and pyridine wherein the substituent(s) are selected from R 15 ; or R 8 and R 9 can be taken together to form -(CH 2 )4~, -(CH 2 )5~ or -CH 2 CH 2 OCH 2 CH 2 - each of which is optionally and independently substituted with 1 or 2 CH3 groups; R!0 is selected from the group H and C1-C4 alkyl; or R 9 and *0 can be taken together to form -(CH 2 )4~, -(CH 2 )5~ or -CH CH OCH CH - each of which is optionally and independently substituted with 1 or 2 CH3 groups; R 11 is selected from halogen, CN, C1-C3 haloalkyl and C1-C3 haloalkoxy; R 12 is C^-C alkyl; R 13 is C1-C4 alkyl; R 14 and R 15 are independently C1-C4 alkyl; or R 14 and R 1 ^ can be taken together as -CH 2 CH CH CH 2 CH - or -CH 2 CH 2 OCH CH -; R1 6 is selected from the group C^-Cg alkyl, C^-Cg haloalkyl, C -Cg alkenyl, C -Cg haloalkenyl, c 2" c 6 alkynyl, C3~Cg haloalkynyl, C 2 -Cg alkoxyalkyl, C 2 -Cg alkylthioalkyl, C^-Cg nitroalkyl, C -Cg cyanoalkyl, C3-C3 alkoxycarbonylalkyl, C3~Cg cycloalkyl, C3~C halocycloalkyl, halogen, CN, N3, SCN, N0 2 , OR 17 , SR 17 , S(0)R 17 , S(0) 2 R 17 , OC(0)R 17 , OS(0) 2 R 17 , C0 R 17 , C(0)R 17 , C(0)NR 17 R 18 , S0 2 NR 17 R 18 , NR 17 R 18 , NR 18 C(0)R 17 , OC(0)NHR 17 , NR 18 C(0)NHR 17 , NR 18 S0 2 R 17 , phenyl optionally substituted with 1 to 3 substituents independently selected from W, and benzyl optionally substituted with 1 to 3 substituents independently selected from W; or when p is 2, (R 16 ) 2 can be taken together as -OCH 0-, -OCF 2 0-, -OCH 2 CH 2 0-, -CH 2 C(CH3) 2 0-, -CF CF 2 0 or -OCF 2 CF 2 0- to form a cyclic bridge; provided that when R 16 is S(0)R 17 , S(0) R 17 , OC(0)R 17 or OS(0) 2 R 17 then R 17 is other than H; R 17 is selected from the group H, C^-C alkyl, Cι~Cg haloalkyl, C -Cg alkenyl, C 2 -Cg haloalkenyl, C -Cg alkynyl, C3~Cg haloalkynyl, C 2 -Cg alkoxyalkyl, C 2 -Cg alkylthioalkyl, Cι~Cg nitroalkyl, C 2 -Cg cyanoalkyl, C3~Cg alkoxycarbonylalkyl, C3~Cg cycloalkyl, C3~C halocycloalkyl, and optionally substituted phenyl and benzyl wherein the substituents are 1 to 3 substituents independently selected from W; R!8 i s selected from the group H and C1-C4 alkyl; or R^- and R^ 8 , when attached to the same atom, can be taken together as -(CH )4-, -(CH )5~, or -CH CH OCH CH 2 -; R 19 is selected from the group H, C1-C alkyl, C 2 -C4 alkenyl, C -C4 alkynyl, C 2 -C4 alkylcarbonyl, C 2 -C alkoxycarbonyl and C1-C4 alkylsulfonyl; R 20 is C1-C3 alkyl; R 1 is selected from the group H, C1-C4 alkyl, C -C alkenyl and C 2 -C4 alkynyl; R 22 is selected from the group H, C -C7 alkylcarbonyl, C 2 -C7 alkoxycarbonyl, optionally substituted C1-C4 alkyl, optionally substituted c 2~ c 4 alkenyl, and optionally substituted C 2 -C4 alkynyl, the substituents selected from Cι~C 2 alkoxy, CN, C(0)R 30 and C(0) 2 R 27 ; R 23 is selected from the group H, C1-C3 alkyl, phenyl, phenyl substituted with W, benzyl and benzyl substituted with W; R 24 is selected from the group H, C1-C4 alkyl, C -C4 alkenyl and C -C4 alkynyl; R 25 and R 26 are independently selected from the group H and Cχ-C 2 alkyl; R 27 is selected from the group C1-C3 alkyl, phenyl and phenyl substituted with W; R 28 is C1-C3 alkyl; R 29 is C1-C3 alkyl; R30 i s gelected from the group H, C1-C3 alkyl, phenyl and phenyl substituted by W; R31 i s selected from the group H, C1-C alkyl, C 2 -C alkylcarbonyl or C 2 -C alkoxycarbonyl; R32 s selected from the group C1-C3 alkyl; R 34 is selected from the group H, Cl, C1-C4 alkyl, c l~ c 4 alkoxy, Cι-C thioalkyl and CN; R35 i s selected from the group H, C1-C alkyl, C 2 -C3 alkylcarbonyl and C 2 -C3 alkoxycarbonyl; R36 i s selected from the group phenyl and phenyl substituted by W; W is selected from the group halogen, CN, N0 2 , Cι~C alkyl, Cι~C 2 haloalkyl, Cι~C 2 alkoxy, Cι~C 2 haloalkoxy, Cι-C 2 alkylthio, Cι~C 2 haloalkylthio, c l~ c 2 alkylsulfonyl and Cι~C 2 haloalkylsulfonyl; m is 1 to 3; n is 1 to 3; p is 1 to 3; r is 0, 1 or 2; t is 2 or 3; and u is 1 or 2. 2 . A compound according to Claim 1 wherein J is selected from the group: J-4 J-5 J-6 J-7 J-8 J-9 CH 3 J-10 J-ll J-l 2 J-l 3 J-14 J-l 5 J-l 6 J-17 J-l 8 J-19 J-20 A compound according to Claim 1 wherein: R^- is selected from the group H, C^-C alkyl, Cι~Cg haloalkyl, C 2 -Cg alkenyl, C -Cg haloalkenyl, C 2 -Cg alkynyl, C3~Cg haloalkynyl, C 2 -Cg alkoxyalkyl, C 2 -Cg 10 alkylthioalkyl, C^-Cg nitroalkyl, C 2 -Cg cyanoalkyl, C3-C8 alkoxycarbonylalkyl, C3~Cg cycloalkyl, C3~Cg halocycloalkyl, halogen, CN, SCN, N0 2 , OR 17 , SR 17 , S0 2 R 17 , C0 2 R 17 , C(0)R 17 , phenyl optionally 15 substituted with 1 to 3 substituents independently selected from W, and benzyl optionally substituted with 1 to 3 substituents independently selected from W; with one R 1 substituent in the 4-position, 20 or when m is 2 then (R 1 ) can be taken together as -CH 2 C(CH 3 ) 2 0-, -OCH 2 CH 0-, -OCF 2 CF 2 0-, or -CF 2 CF 2 0- to form a 5- or 6-membered fused ring; R 2 is selected from the group H, C^-Cg alkyl, 25 C^-Cg haloalkyl, C 2 -Cg alkenyl, C 2 -Cg haloalkenyl, C -Cg alkynyl, C3~Cg haloalkynyl, C 2 -Cg alkoxyalkyl, C -Cg alkylthioalkyl, Cι~Cg nitroalkyl, C 2 -Cg cyanoalkyl, C3-C8 alkoxycarbonylalkyl, 5 c 3~ c 6 cycloalkyl, C3~Cg halocycloalkyl, halogen, CN, SCN, N0 , OR 17 , SR 17 , S(0) 2 R 17 , OC(0)R 17 , OS(0) R 17 , C0 2 R 17 , C(0)R 17 , C(0)NR 17 R 18 , S0 2 NR 17 R 18 , NR 17 R 18 , phenyl optionally substituted with 1 to 3 10 substituents independently selected from W, and benzyl optionally substituted with 1 to 3 substituents independently selected from W; R 3 is selected from the group H, C1-C4 alkyl, 15 c 3~ c 4 alkoxycarbonylalkyl, C0 2 R 17 , C(0)R 17 , phenyl and phenyl substituted by (R 16 ) p ; R1 6 is selected from the group C^-Cg alkyl, C]_-Cg haloalkyl, C 2 -Cg alkenyl, C -Cg haloalkenyl, C 2 -Cg alkynyl, C3~C 20 haloalkynyl, C -Cg alkoxyalkyl, C 2 -Cg alkylthioalkyl, C^-Cg nitroalkyl, C 2 -Cg cyanoalkyl, C3-C8 alkoxycarbonylalkyl, C3~Cg cycloalkyl, C3~Cg halocycloalkyl, halogen, CN, SCN, N0 , OR 17 , SR 17 , 25 S(0) 2 R 17 , OC(0)R 17 , OS(0) R 17 , C0 2 R 17 , C(0)R 17 , C(0)NR 17 R 18 , S0 2 NR 1 R 18 , NR 17 R 18 , phenyl optionally substituted with 1 to 3 substituents independently selected from W, and benzyl optionally substituted with 1 to 30 3 substituents independently selected from W; R1 7 is selected from the group C1-C4 alkyl, c l~ c 2 haloalkyl, C3-C4 alkenyl and propargyl; 35 R 18 is selected from the group H and CH3; X 1 is selected from the group Cl, OR 8 , SR 8 and N(CH 3 ) 2 ; X 2 is selected from the group R 8 , OR 8 and N(CH 3 ) 2 ; m is 1 or 2; n is 1 or 2; and p is 1 or 2. 4. A compound according to Claim 3 wherein G is selected from the group G-2, G-3, G-7 and G-9. 5. A compound according to Claim 4 wherein J is selected from the group J-l, J-2, J-8, J-9 and J-l6. 6. A compound according to Claim 5 wherein A and E are taken together to form -0-, -CH 2 -, -CH 2 CH 2 -, -OCH 2 -, -S-, -SCH 2 - or NR 7 ; R 7 is selected from the group H, Me, S0 2 R 17 , C0 R 17 and CON(R 17 )R 21 . 7. A compound according to Claim 6 of Formula I wherein Z-- is O. 8. A compound according to Claim 6 of Formula I wherein Z-- is S. 9. A compound according to Claim 6 of Formula I wherein Z~- is NR 3 ^-. 10. A compound according to Claim 7 wherein Q is Q-l. 11. A compound according to Claim 7 wherein Q is Q-2. 12. A compound according to Claim 7 wherein Y is c l~ c 6 alkyl. 13. A compound according to Claim 12 wherein Y is CH 3 . 14. A compound according to Claim 10: methyl 7-chloro-2,3-dihydro-2-[[4-trifluoro- methoxy)phenylamino]carbonyl]indeno[1,2-e]- [1,3,4]oxadiazine-4a(5H)-carboxylate. 15. A compound according to Claim 13: methyl 7-chloro-2,5-dihydro-2-[N-methyl-N-[4- (trifluoromethoxy)phenyl]aminocarbonyl]indeno- [1,2-e] [1,3,4]oxadiazine-4a(3H)-carboxylate. 16. A compound according to Claim 13: methyl 7-chloro-2,5-dihydro-2-[[N-methyl-N-[4- trifluoromethyl)phenyl]amino]carbonyl]indeno- [1,2-e] [1,3, ]oxadiazine-4a(3H)-carboxylate. 17. A compound according to Claim 10: 7-fluoro-4a-(4-fluorophenyl)-4a,5-dihydro-N-[4- (trifluoromethoxy)phenyl]indeno[1,2-e] [1,3,4]- oxadiazine-2(3H)-carboxamide. 18. A compound according to Claim 10: 7-chloro-4a,5-dihydro-4a-methyl-N-[4- (trifluoro-methoxy)phenyl]indeno[1,2- e] [1,3,4]oxadiazine-2 (3H)-carboxamide. 19. An arthropodicidal composition comprising a compound according to any one of Claims 1 to 18 and a carrier therefor. 20. A method for controlling arthropods comprising contacting them or their environment with an arthropodicidally effective amount of a compound according to any one of Claims 1 to 18.

Inventors: ANNIS GARY DAVID, BARNETTE WILLIAM ELDO, MCCANN STEPHEN FREDERICK, WING KEITH DUMONT, ANNIS, GARY, DAVID, BARNETTE, WILLIAM, ELDO, MCCANN, STEPHEN, FREDERICK, WING, KEITH, DUMONT
Applicants: DU PONT, E.I. DU PONT DE NEMOURS AND COMPANY
Application year: 1991
Main classification: C07D253
IPC codes: A01N43, A01N47, A01N55, A01N57, A01P7, C07D253, C07D273, C07D285, C07D401, C07D403, C07D405, C07D409, C07D413, C07D417, C07D471, C07D487, C07D498, C07F7, C07F9